Sie sind auf Seite 1von 17

Journal of Microbiological Methods 79 (2009) 139–155

Contents lists available at ScienceDirect

Journal of Microbiological Methods


j o u r n a l h o m e p a g e : w w w. e l s ev i e r. c o m / l o c a t e / j m i c m e t h

Review

Enzymatic substrates in microbiology☆


Sylvain Orenga a,⁎, Arthur L. James b, Mohammed Manafi c, John D. Perry b,d, David H. Pincus e
a
Research & Development Microbiology, bioMérieux, 3 route de Port Michaud, 38 390 La Balme-les-Grottes, France
b
Department of Applied Sciences, University of Northumbria, Newcastle upon Tyne, United Kingdom
c
Hygiene-Institute, Medical University of Vienna, Austria
d
Department of Microbiology, Freeman Hospital, Newcastle upon Tyne, United Kingdom
e
Research & Development Microbiology, bioMérieux, Saint Louis, MO, United States

a r t i c l e i n f o a b s t r a c t

Article history: Enzymatic substrates are powerful tools in biochemistry. They are widely used in microbiology to study
Received 19 May 2009 metabolic pathways, to monitor metabolism and to detect, enumerate and identify microorganisms.
Received in revised form 24 July 2009 Synthetic enzymatic substrates have been customized for various microbial assays, to detect an expanding
Accepted 3 August 2009
range of both new enzymatic activities and target microorganisms.
Available online 11 August 2009
Recent developments in synthetic enzymatic substrates with new spectral, chemical and biochemical
Keywords:
properties allow improved detection, enumeration and identification of food-borne microorganisms, clinical
Chromogenic medium pathogens and multi-resistant bacteria in various sample types. In the past 20 years, the range of synthetic
Detection enzymatic substrates used in microbiology has been markedly extended supporting the development of new
Identification multi-test systems (e.g., Microscan, Vitek 2, Phoenix) and chromogenic culture media. The use of such
Synthetic enzymatic substrate substrates enables an improvement in time to detection and specificity over conventional tests that employ
natural substrates.
In the era of intense developments in molecular biology, phenotypic tests involving enzymatic substrates
remain useful to analyse both simple and complex samples. Such tests are applicable to diagnostic and
research laboratories all over the world.
© 2009 Elsevier B.V. All rights reserved.

Contents

1. Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
M
. etabolic substrates, from natural to synthetic substrates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
2. Synthetic enzymatic substrates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
2.1. Fluorogenic substrates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
2.2. Chromogenic substrates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
2.3. Luminogenic substrates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
2.4. Secondary reaction based substrates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
2.5. Suicide substrates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
3. Microbial enzymatic activities . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
3.1. Hydrolases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
3.2. Nitroreductases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
3.3. Luciferases . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
4. Enzymatic substrates in identification (ID) systems . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 144
5. Application of enzyme substrates in culture media for microbiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
5.1. Chromogenic media for clinical microbiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
5.1.1. Urinary tract pathogens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
5.1.2. Salmonella . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 147
5.1.3. S. aureus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
5.1.4. Differentiation of yeasts . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148

☆ Sponsor: Pr. A. Van Belkum — Erasmus Universiteit Medical Centre, Department of Medical Microbiology and Infectious Diseases, Room L-248, 's-Gravendijkwal 230, 3015 CE
Rotterdam, The Netherlands, Email: mailto:a.vanbelkum@erasmusmc.nl.
⁎ Corresponding author. Tel.: +33 4 74 95 25 43; fax: +33 4 74 95 26 43.
E-mail address: sylvain.orenga@eu.biomerieux.com (S. Orenga).

0167-7012/$ – see front matter © 2009 Elsevier B.V. All rights reserved.
doi:10.1016/j.mimet.2009.08.001
140 S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155

5.1.5. Group B Streptococcus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148


5.1.6. Antibiotic-resistant bacteria . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.1.7. P. aeruginosa . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.2. Fluorogenic and chromogenic media in food and water microbiology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.2.1. E. coli and coliforms . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.2.2. E. coli O157:H7 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.2.3. Salmonella . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.2.4. Shigella spp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.2.5. C. sakazakii . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.2.6. Y. enterocolitica . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
5.2.7. Vibrio spp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
5.2.8. Enterococci . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
5.2.9. C. perfringens . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
5.2.10. L. monocytogenes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
5.2.11. B. cereus and Bacillus thuringiensis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
5.2.12. Bacillus anthracis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
6. Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
Disclosure statement . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
Acknowledgment . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 150

1. Introduction lower toxicity at pH 7.0 (Chilvers et al., 2001). Consequently, after 6 h


incubation, the relative fluorescence produced by coliform bacteria grow-
Metabolic substrates, from natural to synthetic substrates ing in the presence of 4-MU-β-galactoside was only 28% of that generated
in the presence of EHC-β-galactoside. Similarly, when enterococci were
To simplify the study of metabolic activities, it is often advantageous incubated with EHC-β-glucoside, the relative fluorescence was tenfold
to use synthetic metabolic substrates that can provide an easily measured higher than that produced with 4-MU-β-glucoside after 7 h incubation
signal such as a variation of absorbance or fluorescence, or to detect an (Perry et al., 2006a).
individual enzymatic activity in a complex metabolic pathway. Such As 4-MU tends to diffuse away from bacterial cells, other substrates
metabolic substrates are used in a wide range of fields and recent reviews may be preferred to demonstrate the localisation of enzymatic activity
have focused on their use in the screening and optimisation of industrial based on fluorescence detection. For example, Huang et al. (1998) used
enzymes (Reymond et al., 2009) or in histochemistry (Kiernan, 2007). In ELF97-phosphate to study the alkaline phosphatase expression of cells
biochemistry and enzymology studies, the follow-up of enzymatic within Klebsiella pneumoniae colonies and biofilm in response to phos-
activity can be based on secondary reactions or rely on separation and phate starvation. In activated sludge samples, a similar phosphatase
sophisticated analytical instruments (Zhong et al., 1999). However, when substrate, 2-(5′-chloro-2′-phosphoryloxyphenyl)-4-[3]-quinazolinone,
a high number of samples or enzymatic reactions have to be tested in a allowed the distinction of three types of colonies: non-fluorescent ones
short period of time, this is often not practical and it is easier to rely on (i.e., no phosphatase activity), fluorescence limited to the colonies
direct detection of the enzymatic products. (i.e., intracellular phosphatase activity) and fluorescent colonies sur-
Synthetic substrates have been used to study microbial enzymatic rounded by a fluorescent halo (i.e., extracellular phosphatase activity)
activities since the early 20th century (Aizawa, 1939). The first ones (Van Ommen Kloeke et al., 1999). To alleviate problems with diffusion of
were based on nitrophenol or nitroaniline (Aizawa, 1939, Lederberg, fluorescein, Zhang et al. (1991) synthesized lipophilic derivatives of
1950). However, the background colour of most microbial culture fluorescein-di-β-D-galactopyranoside, so the released fluorophore was
media is close to the yellow colour of these compounds (Manafi and retained in the cells, allowing quantitation of β-galactosidase in yeast
Kneifel, 1990). Moreover, the colour of nitrophenol is dramatically cells.
reduced at acid pH. Also, colorimetric detection of naphthol or Fluorogenic substrates have been designed with ‘intramolecular
naphthylamine based substrates relies on an end-point reaction with quenching’ whereby a fluorophore is bound in close proximity of a
a diazonium salt (Monget, 1975), which is not adapted to kinetic chromophore. Before hydrolysis, the chromophore quenches the
analyses. Different groups of enzymatic substrates are more suited to fluorescence but subsequent cleavage of any bond situated between
certain applications depending on a) the targeted enzymatic activity, the two interacting groups, results in a marked increase in fluorescence
b) the mode of detection, and c) the type of reactional medium (Carmel et al., 1977). The enzymatically cleaved peptide bond of
(Table 1). intramolecularly quenched fluorogenic substrates could be similar to
the one of the natural substrate. Consequently, such substrates are very
2. Synthetic enzymatic substrates useful to determine the true characteristics of peptidase. However, this
is not true when the assay mixture contains contaminating fluoro-
2.1. Fluorogenic substrates phores or quenchers (Vencill et al., 1985).

Fluorogenic substrates are widely used in microbiology. Most


of them are based on the fluorescent coumarin heterocycle, either as 2.2. Chromogenic substrates
4-methylumbelliferone (4-MU), e.g., for detection of glycosidases and
phosphatases, or as 7-amino-4-methylcoumarin for the detection of pep- Indoxyl based substrates initially developed for histochemistry
tidases (Goodfellow et al., 1990). However, the fluorescence of the 4-MU (Barrnett and Seligman, 1951) are widely used in microbiology
is markedly reduced at low pH. 3-cyano-4-trifluoromethylumbelliferone because the indigoid dye formed upon oxidation of liberated indoxyl
having a lower pKa than 4-MU, is better adapted for the design of contrasts strongly from the colour of microbial media and precipitates
substrates for enzymatic assay at low pH (Markaryan and Voznyi, 1992). within colonies. Depending on the substituents on the indole ring, the
Similarly, ethyl 7-hydroxycoumarin-3-carboxylate (EHC) has a relative colour of the indigoid dyes ranges from blue to red (Sadler and
fluorescence five times higher than that of 4-MU at pH 6.0 and a slightly Warren, 1956, Kiernan, 2007).
S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155 141

As the indigoid dyes formed upon intracellular hydrolysis of Ichibangase et al. (2004) designed a chemiluminescence assay for lipase
indoxyl based substrates remain inside cells, they can be used for using the lauric acid ester of 2-(4-hydroxyphenyl)-4,5-diphenylimidazole
single cell characterization (Poulsen et al., 1997). (HDI) as a substrate. The generated HDI acts as an enhancer of the
Bainbridge et al. (1991) tried to develop substrates with higher chemiluminescence reaction of luminol–hydrogen peroxide–horseradish
water solubility and lower cost than their indoxyl equivalent. However, peroxidase. While this approach was successful for the assay of lipase
their proposed 2-(2-(4-(β-D-galactopyranosyloxy)-3-methoxyphenyl)- from Candida cylindracea and from porcine pancreas, it seems limited to
vinyl)-3-methylbenzothiazolium toluene-4-sulphonate had to be used assay free enzyme rather than analyse whole living cells. To increase the
with either filter paper or nitrocellulose membranes and in a limited pH sensitivity of the detection of β-galactosidase activity from coliform cells,
range. The application on colonies of a filter paper impregnated with the Van Poucke and Nelis (1995 introduced a permeabilization step with
enzymatic substrate was also required for the lipase substrates based on polymyxin B between the induction of cellular enzymatic activity and the
5-(4-hydroxy-3,5-dimethoxyphenylmethylene)-2-thioxothiazoline-3- measurement of luminescence produced in the presence of a chloro
acetic acid (Miles et al., 1992). Cooke et al. (2002) overcame this derivative of 3-{4-methoxyspiro [1,2-dioxetane-3,2′-tricyclo(3.3.1.13,7)
limitation in a chromogenic medium for Candida with a closely related decan]-yl}phenyl-β-D-galactopyranoside. The phosphatidylinositol-
substrate targeting hexosaminidase activity: 4-(2-[4-(2-acetamido-2- phospholipase C activity from culture supernatant of Bacillus cereus
deoxy-β-D-glucopyranosyloxy)-3-methoxyphenyl]-vinyl)-1-(propan- was detected with a luminogenic substrate based on an adamantane–
3-yl-oate)-quinolium bromide (VLPA-GlcNAc). On their medium, more dioxetane–phenyl group (Ryan et al., 1993).
yeast species hydrolysed the hexosaminidase substrate to produce pink The bioluminogenic substrate D-luciferin-o-β-galactopyranoside is
to red colonies than on chromogenic media incorporating 5-bromo-4- cleaved by β-galactosidase to release luciferin. This luciferin serves as
chloro-3-indoxyl-N-acetyl-β-D-glucosaminide. a substrate for luciferase (Geiger et al., 1992). For microorganism
To overcome some limitations of indoxyl based substrates and analysis, it is combined with a detergent that lyses cells to release the
especially the costs and the requirement of aerobic incubation, James β-galactosidase present (de Almeida et al., 2008).
et al. (2000a) synthesized p-naphtholbenzein-β-D-galactopyranoside
(pNB-gal). When incorporated in agar media, β-galactosidase pro- 2.4. Secondary reaction based substrates
ducing colonies were pink. For similar reasons, James et al. (2000b)
synthesized alizarin-β-D-galactoside (Aliz-gal). Upon hydrolysis, the In some cases, the detection of enzymatic activity still relies on
generated alizarin chelates with ferrous or aluminium ions forming detection of the natural metabolic product. This is the case for
brightly coloured complexes. tryptophanase that metabolises tryptophan to generate indole. The
When tested on strains of Enterobacteriaceae in the presence indole may be detected by reaction with various aldehydes such as 4-
of isopropyl-β-D-thiogalactopyranoside (IPTG), the sensitivity of dimethylaminobenzaldehyde (DMABA), 4-dimethylaminocinnamalde-
pNB-gal was equivalent to that of X-β-D-galactopyranoside (X-gal) hyde (DMACA), or 2-methoxy-4-dimethylaminobenzaldehyde (James
except for some strains of Serratia and Yersinia enterocolitica (James et al., 1986).
et al., 2000a). With Aliz-gal, the sensitivity was slightly higher than Due to low sensitivity of L-alanyl-p-nitroanilide for detecting the
with X-gal for some strains of Serratia and Yersinia (James et al., D-alanyl-D-alanyl dipeptidase VanX from vancomycin-resistant entero-
2000b). cocci, Anissimova et al. (2003) developed an assay based on D-alanyl-α-
To detect β-glucuronidase activity of colonies of Escherichia coli, (R)-phenylthioglycine. The released α-phenylthioglycine was detected
James and Yeoman (1988) used 8-hydroxyquinoline-β-D-glucuronide. upon reaction with 5,5′-dithio-bis-(2-nitrobenzoic acid) (Ellman's re-
The released 8-hydroxyquinoline chelates with ferrous ions present agent) and could be continuously monitored spectrophotometrically.
in the medium generating an intense black pigmentation, but the
sensitivity was lower than that observed with 4-MU-β-D-glucuronide. 2.5. Suicide substrates
Black pigmentation is also obtained with the use of substrates based on
3,4-cyclohexenoesculetin (James et al., 1996, 1997), 3′,4′-dihydroxy- As in oncology, microbiologists use some enzymatic activities to
flavone (Butterworth et al., 2004) and 3-hydroxyflavone (Perry et al., inhibit specifically bacteria expressing those activities. While the
2006a). In those cases, the sensitivity was similar to that obtained with toxicity of the substrate is very low, one of the products of the
indoxyl substrates for similar enzymatic activities. metabolism is highly toxic. It is useful especially with intracellular
Aminophenyl-acridine based substrates can be used for peptidase enzymatic activities such as the β-galactosidase of E. coli (Park et al.,
detection (James et al., 2007). The 9-(4′-aminophenyl)-acridines are pale 1976). The application of this technology has been further extended
yellow, but when protonated either as an acridinium salt or by the application of phosphonopeptides (Perry et al., 2002).
upon addition of acetic acid after incubation, they turn red. Anderson
et al. (2008) used such novel chromogenic peptidase substrates based on 3. Microbial enzymatic activities
9-(4′-aminophenyl)-10-methylacridinium salts for direct detection of
microbial peptidase in colonies on agar plate media. Some of them appear 3.1. Hydrolases
useful for differentiation among enterobacteria species. Chromogenic
peptidase substrates can also be based on derivatives of 7-amino- Most of the synthetic enzymatic substrates used in microbiology are
phenoxazin-3-one (resorufamine, Zaytsev et al., 2008). The 1-pentyl substrates targeting hydrolases (Fig. 2). In particular, a wide range of
substituted derivative (pentylresorufamine, PRF) localises in the bacterial glycosidases, has been exploited as enzymatic targets (Manafi et al.,
cells, producing purple colonies on agar plate media (Fig. 1), but the L- 1991). Substrates for β-ribofuranosidase appear useful for differentia-
alanyl-PRF was inhibitory to Gram-positive bacteria. tion between Y. enterocolitica, which does not hydrolyse these sub-
strates, and most other enterobacteria, which are positive (Butterworth
2.3. Luminogenic substrates et al., 2004). A complex glycoside, 5-bromo-4-chloro-3-indoxyl-5′-
acetamido-3′,5′-dideoxy-α-D-glycero-D-galacto-2-nonulopyranosido-
Luminescence enables detection with high sensitivity and wide nic acid, is hydrolysed by a neuraminidase from Clostridium perfringens
dynamic range. The free enzyme assay of β-D-galactosidase based on producing an insoluble indigoid dye upon aerobic oxidation (Fujii et al.,
the chemiluminogenic substrate o-aminophthalylhydrazide-β-D-galacto- 1993). However, as C. perfringens requires an anaerobic atmosphere, it is
side has a sensitivity 10 times higher than the fluorometric method based not adapted to direct detection of growing C. perfringens strains.
on 4-MU-β-D-galactoside and 100 times higher than the colorimetric Deoxyribonuclease activity is expressed by Staphylococcus aureus
method based on o-nitrophenyl-β-D-galactoside (Nakazono et al., 1992). but not by Staphylococcus epidermidis. This could be used to differentiate
142
Table 1
Examples of chromogenic and fluorogenic synthetic enzymatic substrates adapted to liquid or solid support applications and according to different groups of enzymatic activities.

S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155


S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155
a Pócsi et al., 1990; b Armstrong et al., 2001; c Pearson et al., 1963; d Rothe et al., 1992.

143
144 S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155

(S1, Sutton et al., 1995) is an alternative substrate for β-lactamases.


Positive reactions are detected by a change of colour from light yellow
to red. Results are very similar to those obtained with nitrocefin but in
a slightly shorter time for S. aureus.

3.2. Nitroreductases

Using fluorogenic synthetic substrates, nitroreductase has been


detected with all microorganisms tested by James et al. (2001). The
sensitivity was stronger with the methyl 7-nitrocoumarin-3-carbox-
ylate than with the other 7-nitrocoumarins.

3.3. Luciferases

While the use of synthetic luminogenic substrates is limited with


intact cells due to reduced penetration of the exogenous substrate, the
emission of bioluminescence from substrate produced internally by
Fig. 1. Hydrolysis of β-alanyl pentylresorufamine by colonies of Pseudomonas genetically modified bacteria is a powerful tool for the study of
aeruginosa after 72 h incubation. pathogen behaviour in intact animals. The luxABCDE operon encodes
simultaneously the luciferase enzyme and the complex synthesizing
both species with adapted substrates such as 5-bromo-4-chloro-3- its fatty aldehyde substrate. Thanks to the very low level of the
indoxyl-thymidine-3′-phosphate (Wolf et al., 1969). background bioluminescence, the luxABCDE operon has been used
Peptidases are useful in differentiation of bacteria (Goodfellow successfully as a highly sensitive reporter for the assessment of
et al., 1987, Manafi et al., 1991). L-Alanine aminopeptidase activity can L. monocytogenes infection of mice (Bron et al., 2006).
differentiate between Gram-negative and Gram-positive bacteria and Table 2 summarises the enzymatic activities and families of syn-
this has been demonstrated using L-alanine-7-amino-4-methylcou- thetic enzymatic substrates used in microbiological applications.
marin (Manafi and Kneifel, 1990) and, more recently, 9-(4′-N-[L-Ala-L-
Ala-L-Ala]aminophenyl)-10-methylacridinium (Anderson et al., 2008). 4. Enzymatic substrates in identification (ID) systems
In contrast, β-alanine aminopeptidase activity is expressed by a more
limited range of Gram-negative bacteria, and β-alanyl-PRF appeared to Initially, tests used for microbial characterization to detect key
be a useful substrate to differentiate Pseudomonas aeruginosa colonies enzymes, e.g., urease and decarboxylases, were based on pH changes
on a culture medium (Zaytsev et al., 2008). after hydrolysis of the active substrate. Seidman and Link (1950) first
While most of the substrates for detection of peptidases are based synthesized the self-indicating enzymatic substrate, o-nitrophenyl-β-
on L-amino acids, D-alanine-p-nitroanilide may be used to differen- D-galactoside, for use in detection of β-galactosidase in E. coli
tiate Listeria monocytogenes (negative) from the other Listeria species (Lederberg, 1950), and its broader application was described later
(positive) (Clark and McLaughlin, 1997). (Le Minor and Ben Hamida, 1962). Subsequently, a wealth of enzymatic
Detection of carboxypeptidase can be achieved by the use of N- substrates became available that could be used for either direct or
benzoyl-amino acids. The generated amino acids then react with indirect detection of enzymes through the release of various chromo-
ninhydrin. With N-benzoyl-L-histidine, it is possible to differentiate phores or fluorophores.
Acinetobacter baumannii and Acinetobacter calcoaceticus (both posi- One of the earliest commercial products to employ the use of such
tive) from most other Gram-negative bacteria (Perry et al., 1998). substrates for microbial ID was api ZYM. Introduced in the mid-1970s
When enzymes hydrolyse peptide bonds between two defined but not associated with any specific database (Monget, 1975), this
amino acids, the intramolecularly quenched fluorogenic substrates are research tool gained widespread use in microbial characterization,
well adapted. This approach has been successfully used by Fleminger e.g., of Gram-negative anaerobes (Tharagonnet et al., 1977), Strepto-
et al. (1982) to detect aminopeptidase P from E. coli. Combined with flow coccaceae (Waitkins et al., 1980), yeasts (Casal and Linares, 1983),
cytometry, it allowed sorting of E. coli cells with active OmpT, a surface- Enterobacter spp. (Muytjens et al., 1984), Gram-negative veterinary
displayed protease, from cells with no OmpT (Olsen et al., 2000). pathogens (Groom et al., 1986), etc., and led to the development of ID
To overcome price and availability limitations of nitrocefin and products targeting specific microbial groups.
pyridine-2-azo-p-dimethylaniline cephalosporin (PADAC), a chromo- With few exceptions, commercial ID products incorporated the use
genic substrate derived from cephalothin named CENTA (Bebrone of enzymatic substrates with other tests (e.g., carbon substrates,
et al., 2001) can be used for detection of every type of β-lactamase nitrogen substrates, growth in the presence of inhibitors). Enzyme
except for the CphA metallo-β-lactamase. However, due to the tests enabled differentiation of otherwise very close species pairs and
absorption spectrum of the leaving group, it is not adapted for direct allowed more rapid results than tests requiring extended periods of
detection of β-lactamase producing colonies on agar plates. Cefesone growth, e.g., utilization of carbohydrates.

Fig. 2. Hydrolysis of synthetic enzymatic substrates.


S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155 145

Table 2
Summary of targeted enzymatic activities, dyes and synthetic enzymatic substrates according to microbiological applications.

Enzyme Dye/substrate Microorganism Sample

Enumeration and isolation Glycosidase α-Galactosidase Indoxyl Salmonella C–Fa


plate medium Indoxyl E. coli O157:H7 C–F
β-Galactosidase Indoxyl Escherichia coli C
Indoxyl E. coli O157:H7 C–F
Indoxyl Coliform, F–W
Indoxyl Staphylococcus saprophyticus C
Alizarin VREb C
α-Glucosidase Indoxyl Cronobacter sakazakii F
Indoxyl Staphylococcus aureus C–F
Indoxyl MRSA C
Indoxyl VRE C
β-Glucosidase Indoxyl KESC C
Indoxyl ESBL producing enterobacteria C
Indoxyl Vibrio C–F
Indoxyl Enterococci C–W
Indoxyl VRE C
Indoxyl Listeria spp F
Indoxyl Candida kefyr, Candida lusitaniae, C
Candida tropicalis
Cellobiosidase Indoxyl Cronobacter sakazakii F
β-Glucuronidase 4-MU, Indoxyl E. coli C–F–W
Indoxyl ESBL producing E. coli C
Indoxyl Streptococcus agalactiae C
β-Ribofuranosidase Indoxyl, 3′,4′-Dihydroxyflavone Yersinia enterocolitica C
Hexosaminidase Indoxyl, VLPA Candida albicans, Candida dubliniensis C
Esterase Lipase Indoxyl Salmonella C–F
PI-PLC Indoxyl Listeria monocytogenes F
PC-PLC Indoxyl Bacillus F
Phosphatase Indoxyl S. aureus C–F
Indoxyl S. agalactiae C
4-MU, Indoxyl Clostridium perfringens F
Indoxyl Candida spp. C
Arylamidase/peptidase β-Alanyl arylamidase 7-Amido-1-pentyl-phenoxazin-3-one Pseudomonas aeruginosa C
Miscellaneous Deoxyribonuclease Indoxyl S. aureus F
Spot test Esterase Lipase 4-MU Salmonella C–F
Arylamidase/peptidase L-Alanyl arylamidase AMC, p-Nitroanilide Gram+/Gram− F
Miscellaneous β-Lactamase Nitrocefin, PADAC, CENTA, Cefesone β-lactamase producing bacteria C
Most probable number Glycosidase β-Glucuronidase 4-MU E. coli F
β-Galactosidase Nitrophenol, 4-MU Coliform F
Cytometry Glycosidase β-Glucuronidase Fluorescein E. coli W
β-Galactosidase Fluorescein Coliform W

Enzyme Dye Microorganism

Multi-test identification device Glycosidase Nitrophenol Aerobic Gram-negative bacteria


(detailed enzymatic activities: see Table 3) Naphthol Aerobic Gram-positive bacteria
Indoxyl Coryneforms
4-MU Yeasts
Resorufin Anaerobes
Fastidious Gram-negative
Esterase Nitrophenol Aerobic Gram-negative bacteria
Naphthol Aerobic Gram-positive bacteria
Indoxyl Coryneforms
4-MU Yeasts
Anaerobes
Fastidious Gram-negative
Arylamidase/peptidase p-Nitroanilide Aerobic Gram-negative bacteria
Naphthylamine Aerobic Gram-positive bacteria
AMC Coryneforms
DCAP Yeasts
Anaerobes
Fastidious Gram-negative
a
C, clinical; F, food; W, water.
b
VRE, vancomycin-resistant enterococci; MRSA, methicillin-resistant Staphylococcus aureus; ESBL, extended spectrum ß-lactamase; KESC, Klebsiella, Enterobacter, Serratia,
Citrobacter.

The late 1970s brought several manual products into the commercial Enzymatic tests became a cornerstone of commercial ID systems,
arena, while automated products were introduced in the 1980s. In the first applied to manual kits with later evolution to automated systems.
1990s and over the last decade, technologic advances (higher levels of Enzymatic tests enabled more rapid identification with incubation
automation, more sophisticated electronics, e.g., optical assemblies, and times as short as 2 h. Although these tests are significantly more rapid
availability of more enzyme substrates) allowed for more rapid and than the more conventional growth-based tests, they may require a
accurate ID methods. Table 3 shows most of the enzymatic substrates higher inoculum density (e.g., with anaerobes and coryneforms),
used in different commercial ID products. which may require additional subculture.
146 S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155

Table 3 Table 3 (continued)


Enzymatic tests and applications in commercial ID products. Enzyme Application
Enzyme Application GNa GP YS AC FN
GNa GP YS AC FN Miscellaneous
Glycosidases Pyrazinamidase
N-acetyl-β-galactosaminidase Xb X X Tryptophan deaminase X X
N-acetyl-β-glucosaminidase X X X X Urease X X X X X
α-Amylase X a
GN, non-fastidious Gram-negative; GP, aerobic Gram-positive except coryneforms;
α-Arabinofuranosidase X YS, yeasts; AC, anaerobes/coryneforms; FN, fastidious Gram-negative.
α-Arabinosidase X X X b
X, used in corresponding identification reagent.
β-Cellobiosidase X X
β-Chitobiosidase X X
α-Fucosidase X The differential capabilities afforded by enzymatic tests have
β-Fucosidase X X enabled development of highly accurate ID methods surpassing those
α-Galactosidase X X X X available previously with only carbon and nitrogen substrate utilization
β-Galactosidase X X X X X
tests. Additionally, an increased use of polyphasic, i.e., phenotypic,
α-Glucosidase X X X X X
β-Glucosidase or esculin X X X X genotypic, and chemotaxonomic, characterization (Vandamme et al.,
hydrolysis 1996) has resulted in better-characterized culture collections and
β-Glucuronidase X X X X stronger knowledge bases also reinforcing the development of highly
α-Maltosidase X accurate phenotypic ID products.
β-Maltosidase X
α-Mannosidase X X
Currently, there are many commercial ID products with essentially
β-Mannosidase X X X equivalent performances and other features, e.g., workflow, cost, etc.,
β-Xylosidase X X X are key for their selection in various laboratories. Commercial ID
product evaluations typically show a wide range of accuracy most
Arylamidases
often due to differences in study design.
Alanyl arylamidase X X
β-Alanyl arylamidase X Influential factors of the study design include species and strain
Alanyl-alanine arylamidase X selection, comparative method(s), database version, etc. It is therefore
Alanyl-phenylalanyl-proline X X X X prudent to focus on several studies rather than a single one. While it is
arylamidase impractical to review all available products, the tables below focus on
Arginine arylamidase X X X X
some of the more widely used products with enzymatic substrates and
Arginyl-arginine arylamidase X
Aspartic acid arylamidase X X X their respective performances. It is noteworthy that some recent
Citrulline arylamidase X evaluations (e.g., Heikens et al., 2005, Layer et al., 2006, Sanguinetti
α-Glutamic acid arylamidase X X et al., 2007, Delmas et al., 2008) compare ID products to molecular
γ-Glutamyl transferase X X X
methods while older evaluations compare ID products to conventional
Glutamyl-glutamic arylamidase X
Glutamyl-glycyl-arginine X methods (e.g., Ruoff and Kunz, 1983, Facklam et al., 1985, O'Hara and
arylamidase Miller, 1992) or to other commercial products (e.g., Endimiani et al.,
Glycine arylamidase X X X X 2002, Stefaniuk et al., 2003, Donay et al., 2004). One cautionary note is
Glycyl-arginine arylamidase X that comparison of one commercial product to another commercial
Glycyl-glycine arylamidase X X X
product may compound an inherent error rate present in the com-
Glycyl-proline arylamidase X
Glycyl-tryptophan arylamidase X parator method. These and other factors can account for wide
Histidine arylamidase X X X differences in observed performances as shown in Tables 4–8.
Hydroxyproline arylamidase X
Isoleucine arylamidase X
5. Application of enzyme substrates in culture media
Leucine arylamidase X X X X
Leucyl-glycine arylamidase X
for microbiology
Lysine arylamidase X X X X
Lysyl-alanine arylamidase X Over the last 20 years, there has been a rapid expansion in the
Methionine arylamidase X X development and commercial availability of chromogenic agar media
Phenylalanine arylamidase X X X
for the detection of pathogenic bacteria and yeasts (Perry and Freydière,
Proline arylamidase X X X X X
Pyrrolidonyl arylamidase X X X X 2007). Such culture media typically contain multiple substrates that
Serine arylamidase X allow bacteria to form coloured colonies based on their enzymatic
Seryl-tyrosine arylamidase X activity. This facilitates the differentiation of species within polymicro-
Tryptophan arylamidase X
bial cultures and the targeting of pathogens with high specificity. When
Tyrosine arylamidase X X X X X
specific pathogens are targeted, selective agents such as antibiotics are
Esterases employed to limit the number of species able to grow.
Acetate esterase X Most media rely upon the inclusion of indoxylic substrates in order
Lipase X X to generate colonies with contrasting colours. For example, the release
Phosphatase X X X X X
of green and red chromogens from two distinct substrates can result
Phospholipase X
in the formation of green, red or purple colonies depending on
Miscellaneous whether one or both enzyme activities are present. Pathogens may
Arginine dihydrolase X X X therefore be differentiated from commensal bacteria by their
Gelatinase X X
possession of either one or both enzymes.
Hippurase X X
Glutamic acid decarboxylase X
Indoxylic glycosidase substrates are employed in the majority of
Indole formation (tryptophanase) X X X chromogenic media used in microbiology laboratories including media
Lysine decarboxylase X for the detection of urinary tract pathogens, Salmonella spp., E. coli
Nitrate reductase X X X X O157:H7, Cronobacter sakazakii, Vibrio, S. aureus, enterococci, group B
Ornithine decarboxylase X X X
streptococci, Listeria and yeasts. The glycosidases targeted are largely
Phenylalanine deaminase X
confined to a narrow range, which includes α- or β-galactosidase, α-
S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155 147

Table 4 Table 5
Products for Enterobacteriaceae (E) and/or non-Enterobacteriaceae (NE). Products for Micrococcaceae and/or Streptococcaceae.

No. Type of % Reference No. Type of taxa % Reference


isolates taxa tested Correct isolates tested Correct

Manual products Manual products


api 20E 245 E 99.2 Hayek and Willis, 1976 api Staph 120 CNSa 88.3 Giger et al., 1984
258 NE 99.0 Appelbaum et al., 1984 212 Staphylococci 86.8 Baldellon and Mégraud, 1985
512 E/NE 98.6 Robinson et al., 1995 200 CNS 85.5 De Paulis et al., 2003
505 E 89.1 Wauters et al., 1995 58 CNS 87.9 Heikens et al., 2005
Crystal E/NF 266 E/NE 94.0 Holmes et al., 1994 api 20 Strep 209 Streptococci 85.2 Appelbaum et al., 1984
512 E/NE 95.5 Robinson et al., 1995 77 Viridans 90.0 Etienne et al., 1984
706 E/NE 88.7 Wauters et al., 1995 251 Streptococci 86.1 Facklam et al., 1984
626 E/NE 87.9 O'Hara et al., 1997 119 Viridans 92.0 Ruoff and Kunz, 1983
api 20 NE 262 NE 91.6 Appelbaum and Leathers, 1984 199 Streptococci 88.4 Watts, 1989
431 NE 97.0 von Graevenitz and Crystal GP 191 All GPC 90.0 von Baum et al., 1998
Zollinger-Iten, 1985 124 Enterococci 82.0 Jackson et al., 2004
229 NE 94.8 Martin et al., 1986 120 CNS 67.5 Kim et al., 2008
123 NE 95.1 Palmieri et al., 1988 ID 32 Staph 440 CNS 95.2 Ieven et al., 1995
201 NE 74.6 Wauters et al., 1995 200 CNS 79.5 Renneberg et al., 1995
ID 32 E 545 E/NE 92.8 Monnet et al., 1994 137 CNS 91.2 Edwards et al., 2001
524 E/NE 77.3 O'Hara and Miller, 1999 rapid ID 32 433 Streptococci and 95.3 Freney et al., 1992
RapID onE 379 E/NE 96.8 Kitch et al., 1994 Strep 156 related Viridans 87.2 Kikuchi et al., 1995
125 E 92.0 Lee et al., 1994 122 Streptococci/enterococci 93.0 Gorm Jensen et al., 1999
RapID NF Plus 345 NE 96.2 Kitch et al., 1992 124 Enterococci 85.0 Jackson et al., 2004
rapid ID 32E 414 E 95.4 Freney et al., 1991b RapID STR 266 Streptococci 97.0 Appelbaum et al., 1986
247 Streptococci 93.9 You and Facklam, 1986
Automated products
MicroScan Rapid 383 E/NE 95.3 Pfaller et al., 1991 Automated products
Neg Combo 3 467 E/NE 91.9 O'Hara and Miller, 1992 MicroScan 283 CNS 97.5 Weinstein et al., 1998
252 E/NE 96.4 O'Hara et al., 1993 Pos ID2 202 Enterococci 81.2 Iwen et al., 1999
MicroScan Rapid 652 E/NE 94.0 Bascomb et al., 1997 104 Staphylococci 94.2 Sáa et al., 1999
Neg ID3 511 E/NE 88.8 O'Hara and Miller, 2000 MicroScan 239 Staphylococci 95.4 Stoakes et al., 1992
134 NE 93.3 O'Hara and Miller, 2002 Rapid Pos 233 CNS 76.0 Grant et al., 1994
Phoenix NID 136 E/NE 95.6 Endimiani et al., 2002 285 CNS 88.7 Weinstein et al., 1998
174 E/NE 93.7 Stefaniuk et al., 2003 Phoenix PID 118 All GPC 89.8 Donay et al., 2004
187 E/NE 93.0 Donay et al., 2004 58 CNS 62.1 Heikens et al., 2005
564 E/NE 89.4 O'Hara, 2006 410 Staphylococci/enterococci 99.3 Carroll et al., 2006a
251 E 94.4 Carroll et al., 2006b 110 CNS 80.0 Layer et al., 2006
VITEK GNI+ 619 E/NE 87.6 O'Hara et al., 1997 200 Streptococci/enterococci 92.0 Brigante et al., 2006
304 E/NE 94.4 Bourbeau and Heiter, 1998 VITEK GPI 507 Streptococci 87.8 Facklam et al., 1985
299 NE 92.3 Sung et al., 2000 495 CNS 85.9 Bannerman et al., 1993
454 E 88.8 O'Hara and Miller, 2003 374 Enterococci 91.4 Willey et al., 1993
VITEK 2 GN 655 E/NE 99.4 Funke and Funke-Kissling, 2004 VITEK 2 GP 364 All GPC 94.5 Funke and Funke-Kissling, 2005
331 E/NE 97.0 Wallet et al., 2005 249 All GPC 94.4 Wallet et al., 2005
426 E/NE 99.5 Renaud et al., 2005 121 Enterococci 100.0 Abele-Horn et al., 2006
416 E/NE 97.1 Schreckenberger et al., 2005 110 CNS 90.9 Layer et al., 2006
168 Staphylococci 87.5 Delmas et al., 2008
120 CNS 95.0 Kim et al., 2008
a
CNS, coagulase negative staphylococci; GPC, Gram-positive cocci.

or β-glucosidase, β-glucuronidase and β-N-acetyl-hexosaminidase


activity. Glycosidase substrates may be combined with other sub-
strates for the detection of phosphatase or esterase activity in order to
target specific pathogens.

substitute the β-glucuronidase substrate for a β-galactosidase substrate.


5.1. Chromogenic media for clinical microbiology This allows detection of E. coli with higher sensitivity (99%) but with a
slightly lower specificity due to the occasional isolation of Citrobacter
5.1.1. Urinary tract pathogens freundii, which also produces β-galactosidase but often fails to express
Infection of the urinary tract is usually diagnosed by semi-quantitative β-glucosidase (Fallon et al., 2002, Perry et al., 2007). Both approaches
culture of urine on agar media. Only a limited number of species are are effective for the isolation and differentiation of bacteria isolated from
commonly found in urine and these can be identified, or at least urine samples (Carricajo et al., 1999).
differentiated from other species, by the inclusion of chromogenic
substrates. β-glucuronidase is expressed by around 94% of clinical isolates 5.1.2. Salmonella
of E. coli (the most common urinary tract pathogen) and is generally not In the diagnosis of gastroenteritis, stool samples are cultured onto
produced by other Gram-negative bacteria present in urine samples agar media to determine the presence of Salmonella spp. This requires
(Kilian and Bülow, 1979). CPS ID 2 medium combines complementary the use of sophisticated media in order to differentiate Salmonella spp.
indoxylic substrates for β-glucuronidase and β-glucosidase to differen- from the large number of other species often present in the sample.
tiate E. coli and highlight β-glucosidase producers such as Klebsiella, En- Chromogenic media for Salmonella use biochemical characteristics
terobacter, Serratia and enterococci. Tryptophan is also included to such as acid formation from carbohydrates or the presence of C8
highlight species of the Proteeae (e.g., Proteus mirabilis) as brown colonies esterase for detection of Salmonella strains. Rambach agar and SM ID
due to their deaminase activity (Mazoyer et al., 1995). were the first media of this type. Rambach agar employs X-Gal for β-D-
An alternative approach employed in several media such as Uriselect galactosidase-positive coliforms, Salmonella strains give red colonies
4, Oxoid Chromogenic UTI medium and CHROMagar Orientation is to because of their ability to produce acid from propylene glycol revealed
148 S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155

Table 6 Table 8
Products for yeasts. Products for Neisseria (N), HACEK (H) group, and Campylobacter (C).

No. % Reference No. Type of taxa % Correct Reference


isolates Correct isolates tested

Manual products Manual products


api Candida 619 95.8 Fricker-Hidalgo et al., 1996 RapID NH 240 N 97.9 Robinson and Oberhofer, 1983
198 91.4 Bernal et al., 1998 187 H 89.8 Doern and Chapin, 1984
159 91.8 Campbell et al., 1999 299 H biotyping 92.0 Doern and Chapin, 1987
202 97.0 Paugam et al., 1999 90 N 94.4 Philip and Garton, 1985
RapID Yeast Plus 300 99.3 Kitch et al., 1996 380 H biotyping 51.6 Munson and Doern, 2007
447 97.6 Espinel-Ingroff et al., 1998 api Campy 100 C 92.0 Huysmans et al., 1995
133 94.0 Heelan et al., 1998 62 C 79.0 Reina et al., 1995
201 96.0 Wadlin et al., 1999 87 C 94.3 Shih, 2000
225 87.1 Smith et al., 1999 api NH 305 N/H 99.7 Barbé et al., 1994
750 95.5 Sanguinetti et al., 2007 380 H biotyping 97.6 Munson and Doern, 2007
VITEK NHI 480 N/H 95.2 Janda et al., 1987
Automated products 380 H biotyping 95.0 Munson and Doern, 2007
MicroScan Rapid 401 91.8 Land et al., 1991
Yeast 357 96.6 St.-Germain and Beauchesne, 1991 Automated products
150 67.0 Riddle et al., 1994 MicroScan HN 423 N/H 94.6 Janda et al., 1989
VITEK YBC 1106 94.3 Land et al., 1984 VITEK 2 NH 188 N/H/C 96.8 Valenza et al., 2007
221 83.3 Pfaller et al., 1988 371 N/H/C 96.5 Rennie et al., 2008b
150 85.0 Riddle et al., 1994
398 97.2 el-Zaatari et al., 1990
409 89.7 Fenn et al., 1994
VITEK 2 YST 97 99.0 Aubertine et al., 2006
623 98.6 Hata et al., 2007 et al., 1999). An alternative means of detecting Salmonella is exploited
750 98.4 Sanguinetti et al., 2007 in ABC medium, which utilizes an indoxylic α-galactoside (hydrolysed
136 94.1 Valenza et al., 2008 by Salmonella) in combination with 3,4-cyclohexenoesculetin-β-D-
galactoside (Perry et al., 1999). In order to improve the selectivity of
media for Salmonella, ‘suicide substrates’ such as alafosfalin have been
by neutral red as the pH indicator. SM ID also incorporates a β-D- exploited (Perry et al., 2002). Such substrates release toxic molecules
galactosidase substrate and glucuronic acid, which is metabolised by when hydrolysed so that commensal bacteria may be selectively
Salmonella spp. In most of the second generation of chromogenic inhibited on the basis of their ability to accumulate and hydrolyse
media, Salmonella is typically targeted by utilizing a substrate for C8 them. E. coli O157:H7 may also be recovered from stool samples
esterase activity. Few other species of Enterobacteriaceae produce C8 using specific chromogenic media designed for food samples (see
esterase and these may be differentiated by incorporation of a below).
substrate for β-galactosidase, or preferably β-glucosidase so that the
detection of lactose fermenting Salmonella is not precluded. Indoxylic 5.1.3. S. aureus
esters (e.g., octanoate or nonanoate) are normally used as substrates S. aureus is the most common cause of wound infection and diagnosis
but other chromogens have been utilized (Cooke et al., 1999; Gaillot is by culture of wound swabs onto culture media. Chromogenic media
have been developed for isolation and identification of this important
pathogen and such media typically employ an indoxylic substrate to
detect phosphatase activity. Phosphatase is produced by other species of
Table 7 staphylococci necessitating the use of complementary glycosidase
Products for anaerobes and coryneforms.
substrates, which are not hydrolysed by S. aureus, e.g., an indoxylic β-
No. % Reference glucoside. The use of a phosphatase substrate is exploited in several
isolates Correct commercially available chromogenic media including CHROMagar
Manual products Staph aureus (Gaillot et al., 2000). An alternative approach is to target
Crystal ANR 322 81.7 Cavallaro et al., 1997 α-glucosidase activity as employed in S. aureus ID (Perry et al., 2003).
ID 32 A 214 96.3 Kitch and Appelbaum, 1989
105 86.3 Grollier et al., 1992
102 96.1 Pattyn et al., 1993 5.1.4. Differentiation of yeasts
460 82.0 Downes et al., 1999 When different species of yeast are present in a polymicrobial
122 95.1 Sperner et al., 1999 culture, they are extremely difficult to distinguish from each other
RapID ANA II 300 87.0 Celig and Schreckenberger, 1991 using conventional media. Chromogenic media have been designed to
566 78.0 Marler et al., 1991
api Coryne 240 97.6
provide differentiation of species and identification of the most
Freney et al., 1991a
177 88.1 Gavin et al., 1992 important pathogenic yeast, Candida albicans. The latter is achieved
160 87.5 Soto et al., 1994 by the incorporation of a β-hexosaminidase substrate, which is
407 90.5 Funke et al., 1997 hydrolysed by C. albicans to generate coloured colonies. CHROMagar
178 91.0 Almuzara et al., 2006
Candida employs a further substrate for phosphatase activity allowing
50 72.0 Adderson et al., 2008
Crystal GP 50 76.0 Adderson et al., 2008 the specific identification of Candida tropicalis, which produces both
RapID CB Plus 86 80.2 Hudspeth et al., 1998 enzymes (Odds and Bernaerts, 1994).
378 80.9 Funke et al., 1998
50 52.0 Adderson et al., 2008 5.1.5. Group B Streptococcus
VITEK ANI 341 83.3 Schreckenberger et al., 1988
During antenatal screening many women are routinely screened
Automated products for the presence of Streptococcus agalactiae (group B Streptococcus) as
MicroScan Rapid 237 76.7 Stoakes et al., 1990 a vaginal commensal since this species may cause severe disease in
Anaerobe neonates. S. agalactiae may be differentiated from other vaginal flora
VITEK 2 ANC 365 95.1 Rennie et al., 2008a
by use of an indoxylic phosphate, which is hydrolysed to produce
251 92.0 Mory et al., 2009
coloured colonies. Phosphatase activity is commonly expressed by
S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155 149

other species of the vaginal flora. It is therefore necessary to include 2000a), which was not achievable by visual or CCD-camera fluores-
one or more complementary glycosidase substrates that are not cence detection (Van Poucke and Nelis, 2000b).
hydrolysed by S. agalactiae to ensure that other species do not
resemble S. agalactiae (Perry et al., 2006b; Tazi et al., 2009). 5.2.2. E. coli O157:H7
Several chromogenic media have been applied to the detection
5.1.6. Antibiotic-resistant bacteria of E. coli O157:H7 from food samples. Most are based on similar
It has become increasingly common to screen hospitalized patients principles; relying on non-acidification from sorbitol and/or rham-
for the presence of antibiotic-resistant bacteria as part of infection- nose and lack of β-D-glucuronidase activity. A second chromogenic
control practices. This practice is well established with respect to substrate (e.g., for α- or β-D-galactosidase) may be used to highlight
limiting the spread of methicillin-resistant S. aureus (MRSA). Patients the presence of E. coli O157:H7 among non-reactive background flora.
found to harbour MRSA (e.g., nasal colonization) may be isolated and The performance of three chromogenic agars: Rainbow Agar O157,
subjected to decontamination therapy in order to limit the spread of CHROMagar O157 (pink colonies) and O157:H7 ID agar (green
this important pathogen. Chromogenic media have been adapted to colonies), with a large collection of verotoxigenic and non-toxigenic
detect resistant bacteria by inclusion of additional selective agents, thus E. coli strains have been tested (Bettelheim, 1998, 2005). Another
ensuring that only resistant strains of the target species are allowed to study compared Rainbow Agar O157, BCM O157:H7 and Fluorocult HC
grow. For example, CHROMagar Staph aureus and S. aureus ID have with the conventional Sorbitol MacConkey and showed the clear
both been adapted for isolation of MRSA by incorporation of methicillin advantage of the chromogenic media for the isolation of E. coli O157:
or a surrogate antimicrobial such as cefoxitin (Flayhart et al., 2005; H7 from raw ground beef and raw drinking milk (Manafi and
Perry et al., 2004). CPS ID 3 medium and CHROMagar Orientation have Kremsmaier, 2001). The behaviour of E. coli O157:H7 was studied
been adapted for detection of Enterobacteriaceae producing extended during the manufacture and ripening of raw goat milk lactic cheeses
spectrum β-lactamases (Glupczynski et al., 2007; Randall et al., 2009). using O157:H7 ID agar and CT-SMAC agar (Vernozy-Rozand et al.,
The screening of stool samples to detect colonization with 2005). In conclusion, O157:H7 ID agar proved to be well suited and
vancomycin-resistant enterococci is also advocated by some author- simplified many of the inherent problems associated with plate
ities and specific chromogenic media have been designed for this confirmation of E. coli O157:H7 using Sorbitol MacConkey agar as the
purpose. Typically, a highly selective medium is used (including subculture medium.
vancomycin) and a single substrate is incorporated for detection of all
enterococci, such as esculin or an indoxylic β-glucoside. Alternatively, 5.2.3. Salmonella
chromID VRE employs a mixture of substrates for detection of α- Chromogenic media for Salmonella detection in clinical samples are
glucosidase and β-galactosidase to allow detection and differentiation also used for food samples. One of the rare studies in food microbiology
of the two most important species; Enterococcus faecalis and Entero- using chromogenic media was done by Schönenbrücher et al. (2008).
coccus faecium (Ledeboer et al., 2007). The draft ISO 6579:2002 was compared to the European gold standard
(DIN EN 12824:1998), including the three new chromogenic plating
5.1.7. P. aeruginosa media AES Salmonella Agar Plate (ASAP), Oxoid Salmonella Chromo-
Recently, a new chromogenic culture medium has been described for genic Medium (OSCM) and Miller-Mallinson agar (MM). Only on MM
the isolation and identification of P. aeruginosa. This is the first agar agar, did all of the 36 tested type strains produce typical colonies,
medium to employ a chromogenic substrate for detection of amino- especially strains of Salmonella Senftenberg, Salmonella arizonae, Sal-
peptidase activity. Among the bacteria encountered clinically, β-alanyl monella Dublin and Salmonella Derby.
aminopeptidase is largely restricted to P. aeruginosa and a few
other Gram-negative species and this activity is detected by inclusion 5.2.4. Shigella spp.
of β-alanyl pentylresorufamine, which is hydrolysed to generate a Warren et al. (2005) described the evaluation of a new chromogenic
purple colouration (Zaytsev et al., 2008). This medium has been medium (CSPM) for detection of Shigella spp. in food microbiology.
employed for the direct identification of P. aeruginosa from the sputa Colony colour enhancements created by CSPM may ease differentiation
of patients with cystic fibrosis (Laine et al., 2009). of Shigella colonies from those of closely related bacteria.

5.2. Fluorogenic and chromogenic media in food and water microbiology 5.2.5. C. sakazakii
C. (Enterobacter) sakazakii is an occasional contaminant of powdered
In recent years, a number of selective chromogenic plating media infant formula that can cause rare but severe food-borne infections in
for detection and enumeration of the most important bacteria in food infants. C. sakazakii possesses α-glucosidase activity, and a number of
and water have been developed and marketed (Manafi, 2000). selective, chromogenic agars for C. sakazakii isolation based on this
enzyme have been developed (Iversen and Forsythe, 2007, Lehner et al.,
5.2.1. E. coli and coliforms 2006, Restaino et al., 2006). The substrate 5-bromo-4-chloro-3-indolyl-
The new generation of media uses β-D-glucuronidase as the α-D-glucopyranoside (X-α-Glc) is added to a basal medium to dif-
indicator for E. coli and β-D-galactosidase as the indicator for coliforms. ferentiate C. sakazakii strains from other members of the Enterobacter-
There are a wide range of media detecting the presence of coliforms iaceae. The enzyme α-glucosidase hydrolyses X-α-Glc giving blue
and E. coli using different chromogenic or fluorogenic enzyme sub- coloured colonies on DFI agar, ESIA agar, chromID Sakazakii or
strates that have been reviewed before (Manafi 1996, 2000). Based on Chromocult Enterobacter sakazakii (CES) (Cawthorn et al., 2008),
such substrates, specific devices have been designed and successfully which are commercially available. A modification of DFI agar supple-
tested for enumeration of E. coli from water samples: Petrifilm E. coli/ mented with glucose (mDFI) was described by Song et al. (2008) to
coliform count plates, m-ColiBlue, Colilert-18 and Quanti-Tray 2000, eliminate false positive results with Escherichia vulneris.
(Vail et al., 2003) or food samples (Tempo EC, Torlak et al., 2008).
Combining solid phase cytometry and separation of the growth/ 5.2.6. Y. enterocolitica
enzyme induction phase from the enzyme activity measurement with Weagant (2008) described an agar for detection of potentially
fluorescein-di-β-glucuronide or fluorescein-di-β-galactopyranoside, virulent Y. enterocolitica (YeCM). This medium contains cellobiose as
it is possible to enumerate E. coli or coliforms from water samples in the fermentable sugar and a chromogenic substrate. Y. enterocolitica
less than 4 h (Nelis and Van Poucke, 2000, Van Poucke and Nelis, biotype 1A and other related Yersinia formed colonies that were
150 S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155

purple/blue on YeCM while they formed typical red bulls-eye colonies 5.2.11. B. cereus and Bacillus thuringiensis
on Cefsulodin-Irgasan-Novobiocin agar. Phosphatidylcholine-specific phospholipase C (PC-PLC), encoded
by the plc genes, is used as a marker for these two microorganisms.
5.2.7. Vibrio spp. Hydrolysis of 5-bromo-4-chloro-3-indoxyl-choline-phosphate yields
Thiosulphate-Citrate-Bile-Sucrose agar used in the laboratory is blue–green colonies, indicating the presence of PC-PLC activity
not very selective and cannot differentiate between different Vibrio (Juergensmeyer et al., 2006). The Chromogenic Bacillus Cereus agar
species. There are new chromogenic media for Vibrio, which enable contains 5-bromo-4-chloro-3-indolyl-β-D-glucopyranoside that is
pathogenic species such as Vibrio parahaemolyticus, Vibrio cholerae, cleaved by β-D-glucosidase and results in white colonies with a
and Vibrio vulnificus to be differentiated on the basis of chromogenic blue–green centre (Fricker et al., 2008).
reactions. Chromochecker Vibrio agar for detection of V. vulnificus
(Nakashima et al., 2007), VVM (Cerdà-Cuéllar et al., 2000), Bio- 5.2.12. Bacillus anthracis
Chrome Vibrio medium (Su et al., 2005) and commercially available The chromogenic R&F Anthracis chromogenic agar (ChrA) is
media CHROMagar Vibrio (Hara-Kudo et al., 2001, Blanco-Abad et al., described and evaluated by Marston et al. (2008). Thirteen of the 16
2009) and chromID Vibrio are new and further evaluation studies are B. anthracis tested strains produced the expected morphology on the
needed. ChrA medium.

5.2.8. Enterococci
6. Conclusion
Substrates such as 5-bromo-4-chloro-3-indolyl-β-D-glucopyranoside
(X-Glu) and indoxyl-β-D-glucoside were already described for de-
Synthetic enzymatic substrates have long been useful for both
tection of β-D-glucosidase activity (Manafi, 2000). Enterococci that are
fundamental microbiology (Jacob and Monod, 1961) and daily analysis
β-glucosidase-positive produce an insoluble indigoid blue complex,
of clinical, food and environmental samples. Despite the development
which diffuses into the surrounding medium, forming a blue halo around
of identification methods based on direct nucleic acid, fatty acid,
the colony. Chromocult Enterococci broth and Readycult Enterococci
protein or antigen analysis, they remain powerful tools for detection,
utilize the β-D-glucosidase reaction as an indicator using X-Glu. The
enumeration and identification of microorganisms giving simulta-
X-Glu is liberated and rapidly oxidized to dibromodichloroindigo, which
neously descriptive and functional information. For the detection of
produces blue colour in Chromocult broth. Chromocult enterococci agar
carbapenemase producing Enterobacteriaceae, they allow for a reduc-
uses a chromogenic mix in a selective agar; enterococci cleave
tion in the use of expensive and complex phenotypic or molecular tests
chromogenic substrates in this medium and show red coloured colonies
to a limited number of presumptive positive isolates (CDC, 2009).
on the plate. Non-enterococci produce colourless, blue/violet or
Finally, thanks to the continuous development of new molecules, they
turquoise colonies (Miranda et al., 2005).
also participate to highlight the microbial complexity, as illustrated by
the number of colony variants of P. aeruginosa isolated from sputum
5.2.9. C. perfringens
samples of cystic fibrosis patients (Laine et al., 2009).
The identification of C. perfringens is possible using Fluorocult
TSCagar using a fluorogenic enzyme substrate. D-Cycloserine inhi-
bits the accompanying bacterial flora and causes the colonies to Disclosure statement
remain smaller. C. perfringens colonies can be detected using 4-MU-
phosphate. Acid phosphatase is a highly specific indicator for C. In the last three years, Arthur James has received financial support
perfringens, which shows a light blue fluorescence on this medium. for consultancy from bioMérieux. He also receives financial remuner-
The new chromoselect CP agar, is now available, which can be used ation from sales of identification devices and a chromogenic medium
in water microbiology. C. perfringens colonies give green coloured supplied by bioMérieux.
colonies, and other clostridia species give violet, or blue coloured In the last three years, John Perry has received financial support for
colonies (Sigma, Switzerland). research or consultancy from suppliers of chromogenic culture media
including bioMérieux, Becton Dickinson and Bio-Rad. He also receives
5.2.10. L. monocytogenes financial remuneration from sales of a chromogenic medium supplied
Several studies have been performed using chromogenic media for by International Diagnostics Group (Lab M).
the detection of L. monocytogenes and are summarised by Reissbrodt David Pincus and Sylvain Orenga have been employed by bioMérieux
(2004). There are two groups of such media: the first, including Agar for the last three years. Sylvain Orenga also received financial re-
Listeria according to Ottaviani and Agosti (ALOA), utilizes cleavage by muneration for patent applications and registrations.
phosphatidylinositol-specific phospholipase C (PI-PLC) of L-α-phospha- Mammad Manafi has no potential conflict to declare.
tidylinositol, forming a white precipitation zone around the colony,
combined with the chromogenic substrate 5-bromo-4-chloro-3-indoxyl- Acknowledgment
β-D-glucopyranoside for detection of β-D-glucosidase, which occurs in
all Listeria spp. The typical colony morphology of Listeria spp. is reported The authors thank Daniel Monget for his broad and rigorous
to be turquoise blue. Pathogenic Listeria colonies are additionally involvement in the field of enzymatic substrates for microbiology
surrounded by a translucent halo. The second group of media utilizes especially for the improvement of microbial identification. By the
5-bromo-4-chloro-3-indoxyl-myoinositol-1-phosphate, forming blue- results of his work as well as by direct training of some of us, he
turquoise colonies of pathogenic Listeria spp.: L. monocytogenes and L. contributed deeply to our knowledge. And even more, he allowed us
ivanovii. A recent paper (Stessl et al., 2009) evaluated six chromogenic to meet and work together in a creative and friendly relationship. As
media similar to ALOA, in addition testing the ability to facilitate growth such, he indirectly inspired and contributed to this review.
of stressed L. monocytogenes strains and mixed cultures with competitive
non-Listeria and enumeration of L. monocytogenes in food samples. They
References
found that the competitive flora of food samples is able to overgrow low
numbers of L. monocytogenes, especially in half-Fraser enrichment. This Abele-Horn, M., Hommers, L., Trabold, R., Frosch, M., 2006. Validation of VITEK 2 version
might lead to the underestimation of L. monocytogenes-positive samples. 4.01 software for detection, identification, and classification of glycopeptide-
resistant enterococci. J. Clin. Microbiol. 44, 71–76.
Examples of such media include CHROMagar Listeria agar, OCLA, Adderson, E.E., Boudreaux, J.W., Cummings, J.R., Pounds, S., Wilson, D.A., Procop, G.W.,
Compass L. mono, chromID OAA and Chromoplate Listeria. Hayden, R.T., 2008. Identification of clinical coryneform bacterial isolates:
S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155 151

comparison of biochemical methods and sequence analysis of 16S rRNA and rpoB Carroll, K.C., Borek, A.P., Burger, C., Glanz, B., Bhally, H., Henciak, S., Flayhart, D.C., 2006a.
genes. J. Clin. Microbiol. 46, 921–927. Evaluation of the BD Phoenix automated microbiology system for identification
Aizawa, K., 1939. Die fermentative Hydrolyse des p-Nitrophenol-β-galactosids — and antimicrobial susceptibility testing of staphylococci and enterococci. J. Clin.
Studien über Carbohydrasen II. Enzymologia 6, 321–324. Microbiol. 44, 2072–2077.
Almuzara, M.N., De Mier, C., Rodríguez, C.R., Famiglietti, A.M., Vay, C.A., 2006. Carroll, K.C., Glanz, B.D., Borek, A.P., Burger, C., Bhally, H.S., Henciak, S., Flayhart, D.,
Evaluation of API Coryne System, version 2.0, for diphtheroid Gram-positive rods 2006b. Evaluation of the BD Phoenix automated microbiology system for
identification with clinical relevance. Rev. Argent. Microbiol. 38, 197–201. identification and antimicrobial susceptibility testing of Enterobacteriaceae. J. Clin.
Anderson, R.J., Groundwater, P.W., Huang, Y., James, A.L., Orenga, S., Rigby, A., Roger- Microbiol. 44, 3506–3509.
Dalbert, C., Perry, J.D., 2008. Synthesis and evaluation of novel chromogenic Casal, M., Linares, M.J., 1983. Contribution to the study of the enzymatic profiles of yeast
peptidase substrates based on 9-(4′-aminophenyl)-10-methylacridinium salts as organisms with medical interest. Mycopathol. 81, 155–159.
diagnostic tools in clinical bacteriology. Bioorg. Med. Chem. Lett. 18, 832–835. Cavallaro, J.J., Wiggs, L.S., Miller, J.M., 1997. Evaluation of the BBL Crystal anaerobe
Anissimova, M., Yaouancq, L., Noor, F., Badet-Denisot, M.A., Badet, B., 2003. New identification system. J. Clin. Microbiol. 35, 3186–3191.
chromogenic dipeptide substrate for continuous assay of the D-alanyl-D-alanine Cawthorn, D.M., Botha, S., Witthuhn, R.C., 2008. Evaluation of different methods for the
dipeptidase VanX required for high-level vancomycin resistance. J. Pept. Res. 62, detection and identification of Enterobacter sakazakii isolated from South African
88–95 Erratum in: J. Pept. Res. 2003. 62, 186. infant formula milks and the processing environment. Int. J. Food Microbiol. 127,
Appelbaum, P.C., Leathers, D.J., 1984. Evaluation of the rapid NFT system for 129–138.
identification of Gram-negative, nonfermenting rods. J. Clin. Microbiol. 20, CDC, 2009. Guidance for control of infections with carbapenem-resistant or
730–734. carbapenemase-producing Enterobacteriaceae in acute care facilities. Morb. Mortal.
Appelbaum, P.C., Chaurushiya, P.S., Jacobs, M.R., Duffett, A., 1984. Evaluation of the Wkly. Rep. 58, 256–260.
rapid strep system for species identification of streptococci. J. Clin. Microbiol. 19, Celig, D.M., Schreckenberger, P.C., 1991. Clinical evaluation of the RapID-ANA II panel
588–591. for identification of anaerobic bacteria. J. Clin. Microbiol. 29, 457–462.
Appelbaum, P.C., Jacobs, M.R., Palko, W.M., Frauenhoffer, E.E., Duffett, A., 1986. Accuracy Cerdà-Cuéllar, M., Jofre, J., Blanch, A.R., 2000. A selective medium and a specific probe
and reproducibility of the IDS rapID STR system for species identification of for detection of Vibrio vulnificus. Appl. Environ. Microbiol. 66, 855–859.
streptococci. J. Clin. Microbiol. 23, 843–846. Chilvers, K.F., Perry, J.D., James, A.L., Reed, R.H., 2001. Synthesis and evaluation of novel
Armstrong, L., James, A.L., Monget, D., Orenga, S., 2001. Novel chromogenous substrates fluorogenic substrates for the detection of bacterial beta-galactosidase. J. Appl.
for detecting bacterial hydrolase. EP1066405. Jan. 10, 2001. Microbiol. 91, 1118–1130.
Aubertine, C.L., Rivera, M., Rohan, S.M., Larone, D.H., 2006. Comparative study of the Clark, A.G., McLaughlin, J., 1997. Simple color tests based on an alanyl peptidase
new colorimetric VITEK 2 yeast identification card versus the older fluorometric reaction which differentiate Listeria monocytogenes from other Listeria species.
card and of CHROMagar Candida as a source medium with the new card. J. Clin. J. Clin. Microbiol. 35, 2155–2156.
Microbiol. 44, 227–228. Cooke, V.M., Miles, R.J., Price, R.G., Richardson, A.C., 1999. A novel chromogenic ester
Bainbridge, B.W., Mathias, N., Price, R.G., Richardson, A.C., Sandhu, J., Smith, B.V., 1991. agar medium for detection of Salmonellae. Appl. Environ. Microbiol. 65, 807–812.
Improved methods for the detection of beta-galactosidase activity in colonies of Cooke, V.M., Miles, R.J., Price, R.G., Midgley, G., Khamri, W., Richardson, A.C., 2002. New
Escherichia coli using a new chromogenic substrate: VBzTM-gal (2-(2-(4-(beta-D- chromogenic agar medium for the identification of Candida spp. Appl. Environ.
galactopyranosyloxy)-3-methoxyphenyl)-vinyl)-3-methylbenzothiazolium toluene- Microbiol. 68, 3622–3627.
4-sulphonate). FEMS Microbiol. Lett. 64, 319–323. de Almeida, R.A., Burgess, D., Shema, R., Motlekar, N., Napper, A.D., Diamond, S.L., Pavitt, G.D.,
Baldellon, C., Mégraud, F., 1985. Characterization of Micrococcaceae strains isolated 2008. A Saccharomyces cerevisiae cell-based quantitative beta-galactosidase assay
from the human urogenital tract by the conventional scheme and a micromethod. compatible with robotic handling and high-throughput screening. Yeast 25, 71–76.
J. Clin. Microbiol. 21, 474–477. De Paulis, A.N., Predari, S.C., Chazarreta, C.D., Santoianni, J.E., 2003. Five-test simple
Bannerman, T.L., Kleeman, K.T., Kloos, W.E., 1993. Evaluation of the Vitek Systems scheme for species-level identification of clinically significant coagulase-negative
Gram-Positive Identification card for species identification of coagulase-negative staphylococci. J. Clin. Microbiol. 41, 1219–1224.
staphylococci. J. Clin. Microbiol. 31, 1322–1325. Delmas, J., Chacornac, J.P., Robin, F., Giammarinaro, P., Talon, R., Bonnet, R., 2008.
Barbé, G., Babolat, M., Boeufgras, J.M., Monget, D., Freney, J., 1994. Evaluation of API NH, Evaluation of the Vitek 2 system with a variety of Staphylococcus species. J. Clin.
a new 2-hour system for identification of Neisseria and Haemophilus species and Microbiol. 46, 311–313.
Moraxella catarrhalis in a routine clinical laboratory. J. Clin. Microbiol. 32, 187–189. Doern, G.V., Chapin, K.C., 1984. Laboratory identification of Haemophilus influenzae:
Barrnett, R.J., Seligman, A.M., 1951. Histochemical demonstration of esterases by effects of basal media on the results of the satellitism test and evaluation of the
production of indigo. Science 114, 579–582. RapID NH system. J. Clin. Microbiol. 20, 599–601.
Bascomb, S., Abbott, S.L., Bobolis, J.D., Bruckner, D.A., Connell, S.J., Cullen, S.K., Doern, G.V., Chapin, K.C., 1987. Determination of biotypes of Haemophilus influenzae
Daugherty, M., Glenn, D., Janda, J.M., Lentsch, S.J., Lindquist, D., Mayhew, P.B., and Haemophilus parainfluenzae a comparison of methods and a description of a
Nothaft, D.M., Skinner, J.R., Williams, G.B., Wong, J., Zimmer, B.L., 1997. Multicenter new biotype (VIII) of H. parainfluenzae. Diag. Microbiol. Infect. Dis. 7, 269–272.
evaluation of the MicroScan Rapid Gram-Negative Identification Type 3 Panel. Donay, J.L., Mathieu, D., Fernandes, P., Prégermain, C., Bruel, P., Wargnier, A., Casin, I.,
J. Clin. Microbiol. 35, 2531–2536. Weill, F.X., Lagrange, P.H., Herrmann, J.L., 2004. Evaluation of the automated
Bebrone, C., Moali, C., Mahy, F., Rival, S., Docquier, J.D., Rossolini, G.M., Fastrez, J., Phoenix system for potential routine use in the clinical microbiology laboratory.
Pratt, R.F., Frère, J.M., Galleni, M., 2001. CENTA as a chromogenic substrate for J. Clin. Microbiol. 42, 1542–1546.
studying beta-lactamases. Antimicrob. Agents Chemother. 45, 1868–1871. Downes, J., King, A., Hardie, J., Phillips, I., 1999. Evaluation of the Rapid ID 32A system
Bernal, S., Martín Mazuelos, E., Chávez, M., Coronilla, J., Valverde, A., 1998. Evaluation of for identification of anaerobic Gram-negative bacilli, excluding the Bacteroides
the new API Candida system for identification of the most clinically important yeast fragilis group. Clin. Microbiol. Infect. 5, 319–326.
species. Diag. Microbiol. Infect. Dis. 32, 217–221. Edwards, K.J., Kaufmann, M.E., Saunders, N.A., 2001. Rapid and accurate identification of
Bettelheim, K.A., 1998. Reliability of CHROMagar O157 for the detection of enterohaemor- coagulase-negative staphylococci by real-time PCR. J. Clin. Microbiol. 39, 3047–3051.
rhagic Escherichia coli (EHEC) O157 but not EHEC belonging to other serogroups. el-Zaatari, M., Pasarell, L., McGinnis, M.R., Buckner, J., Land, G.A., Salkin, I.F., 1990.
J. Appl. Microbiol. 85, 425–428. Evaluation of the updated Vitek yeast identification data base. J. Clin. Microbiol. 28,
Bettelheim, K.A., 2005. Reliability of O157:H7 ID agar (O157 H7 ID-F) for the detection 1938–1941.
and isolation of verocytotoxigenic strains of Escherichia coli belonging to serogroup Endimiani, A., Luzzaro, F., Tamborini, A., Lombardi, G., Elia, V., Belloni, R., Toniolo, A.,
O157. J. Appl. Microbiol. 99, 408–410. 2002. Identification and antimicrobial susceptibility testing of clinical isolates of
Blanco-Abad, V., Ansede-Bermejo, J., Rodriguez-Castro, A., Martinez-Urtaza, J., 2009. nonfermenting Gram-negative bacteria by the Phoenix automated microbiology
Evaluation of different procedures for the optimized detection of Vibrio parahaemo- system. New Microbiol. 25, 323–329.
lyticus in mussels and environmental samples. Int. J. Food Microbiol. 129, 229–236. Espinel-Ingroff, A., Stockman, L., Roberts, G., Pincus, D., Pollack, J., Marler, J., 1998.
Bourbeau, P.P., Heiter, B.J., 1998. Comparison of Vitek GNI and GNI+ cards for Comparison of RapID Yeast Plus system with API 20C system for identification of
identification of Gram-negative bacteria. J. Clin Microbiol. 36, 2775–2777. common, new, and emerging yeast pathogens. J. Clin. Microbiol. 36, 883–886.
Brigante, G., Luzzaro, F., Bettaccini, A., Lombardi, G., Meacci, F., Pini, B., Stefani, S., Etienne, J., Reverdy, M.E., Gruer, L.D., Delorme, V., Fleurette, J., 1984. Evaluation of the
Toniolo, A., 2006. Use of the Phoenix automated system for identification of API 20 STREP system for species identification of streptococci associated with
Streptococcus and Enterococcus spp. J. Clin. Microbiol. 44, 3263–3267. infective endocarditis. Eur. Heart J. 5 (Suppl C), 25–27.
Bron, P.A., Monk, I.R., Corr, S.C., Hill, C., Gahan, C.G., 2006. Novel luciferase reporter Facklam, R.R., Rhoden, D.L., Smith, P.B., 1984. Evaluation of the Rapid Strep system for
system for in vitro and organ-specific monitoring of differential gene expression in the identification of clinical isolates of Streptococcus species. J. Clin. Microbiol. 20,
Listeria monocytogenes. Appl. Environ. Microbiol. 72, 2876–2884. 894–898.
Butterworth, L.A., Perry, J.D., Davies, G., Burton, M., Reed, R.H., Gould, F.K., 2004. Evaluation Facklam, R., Bosley, G.S., Rhoden, D., Franklin, A.R., Weaver, N., Schulman, R., 1985.
of novel beta-ribosidase substrates for the differentiation of Gram-negative bacteria. J. Comparative evaluation of the API 20S and AutoMicrobic Gram-positive identifi-
Appl. Microbiol. 96, 170–176. cation systems for non-beta-hemolytic streptococci and aerococci. J. Clin. Microbiol.
Campbell, C.K., Davey, K.G., Holmes, A.D., Szekely, A., Warnock, D.W., 1999. Comparison 21, 535–541.
of the API Candida system with the AUXACOLOR system for identification of Fallon, D., Andrews, N., Frodsham, D., Gee, B., Howe, S., Iliffe, A., Nye, K.J., Warren, R.E.,
common yeast pathogens. J. Clin. Microbiol. 37, 821–823. 2002. A comparison of the performance of cystine lactose electrolyte deficient
Carmel, A., Kessler, E., Yaron, A., 1977. Intramolecularly-quenched fluorescent peptides (CLED) agar with Oxoid chromogenic urinary tract infection (CUTI) medium for the
as fluorogenic substrates ofleucine aminopeptidase and inhibitors of clostridial isolation and presumptive identification of organisms from urine. J. Clin. Pathol. 55,
aminopeptidase. Eur. J. Biochem. 73, 617–625. 524–529.
Carricajo, A., Boiste, S., Thore, J., Gille, Y., Aubert, G., Freydière, A.M., 1999. Comparative Fenn, J.P., Segal, H., Barland, B., Denton, D., Whisenant, J., Chun, H., Christofferson, K.,
evaluation of five chromogenic media for detection, enumeration and direct Hamilton, L., Carroll, K., 1994. Comparison of updated Vitek Yeast Biochemical Card
identification of urinary tract pathogens. Eur. J. Clin. Microbiol. Infect. Dis. 18, 796–803. and API 20C yeast identification systems. J. Clin. Microbiol. 32, 1184–1187.
152 S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155

Flayhart, D., Hindler, J.F., Bruckner, D.A., Hall, G., Shrestha, R.K., Vogel, S.A., Richter, S.S., Heikens, E., Fleer, A., Paauw, A., Florijn, A., Fluit, A.C., 2005. Comparison of genotypic and
Howard, W., Walther, R., Carroll, K.C., 2005. Multicenter evaluation of BBL phenotypic methods for species-level identification of clinical isolates of coagulase-
CHROMagar MRSA medium for direct detection of methicillin-resistant Staphylo- negative staphylococci. J. Clin. Microbiol. 43, 2286–2290.
coccus aureus from surveillance cultures of the anterior nares. J. Clin. Microbiol. 43, Holmes, B., Costas, M., Thaker, T., Stevens, M., 1994. Evaluation of two BBL Crystal
5536–5540. systems for identification of some clinically important Gram-negative bacteria.
Fleminger, G., Carmel, A., Goldenberg, D., Yaron, A., 1982. Fluorogenic substrates for J. Clin. Microbiol. 32, 2221–2224.
bacterial aminopeptidase P and its analogs detected in human serum and calf lung. Huang, C.T., Xu, K.D., McFeters, G.A., Stewart, P.S., 1998. Spatial patterns of alkaline
Eur. J. Biochem. 125, 609–615. phosphatase expression within bacterial colonies and biofilms in response to
Freney, J., Duperron, M.T., Courtier, C., Hansen, W., Allard, F., Boeufgras, J.M., Monget, D., phosphate starvation. Appl. Environ. Microbiol. 64, 1526–1531.
Fleurette, J., 1991a. Evaluation of API Coryne in comparison with conventional Hudspeth, M.K., Hunt Gerardo, S., Citron, D.M., Goldstein, E.J.C., 1998. Evaluation of the
methods for identifying coryneform bacteria. J. Clin. Microbiol. 29, 38–41. RapID CB Plus system for identification of Corynebacterium species and other Gram-
Freney, J., Herve, C., Desmonceaux, M., Allard, F., Boeufgras, J.M., Monget, D., Fleurette, J., positive rods. J. Clin. Microbiol. 36, 543–547.
1991b. Description and evaluation of the semiautomated 4-hour ATB 32E method Huysmans, M.B., Turnidge, J.D., Williams, J.H., 1995. Evaluation of API Campy in
for identification of members of the family Enterobacteriaceae. J. Clin. Microbiol. 29, comparison with conventional methods for identification of thermophilic campy-
138–141. lobacters. J. Clin. Microbiol. 33, 3345–3346.
Freney, J., Bland, S., Etienne, J., Desmonceaux, M., Boeufgras, J.M., Fleurette, J., 1992. Ichibangase, T., Ohba, Y., Kishikawa, N., Nakashima, K., Kuroda, N., 2004. Chemilumi-
Description and evaluation of the semiautomated 4-hour rapid ID 32 Strep method nescence assay of lipase activity using a synthetic substrate as proenhancer for
for identification of streptococci and members of related genera. J. Clin. Microbiol. luminol chemiluminescence reaction. Luminescence 19, 259–264.
30, 2657–2661. Ieven, M., Verhoeven, J., Pattyn, S.R., Goossens, H., 1995. Rapid and economical method
Fricker, M., Reissbrodt, R., Ehling-Schulz, M., 2008. Evaluation of standard and new for species identification of clinically significant coagulase-negative staphylococci.
chromogenic selective plating media for isolation and identification of Bacillus J. Clin. Microbiol. 33, 1060–1063.
cereus. Int. J. Food Microbiol. 121, 27–34. Iversen, C., Forsythe, S.J., 2007. Comparison of media for the isolation of Enterobacter
Fricker-Hidalgo, H., Vandapel, O., Duchesne, M.A., Mazoyer, M.A., Monget, D., Lardy, B., sakazakii. Appl. Environ. Microbiol. 73, 48–52.
Lebeau, B., Freney, J., Ambroise-Thomas, P., Grillot, R., 1996. Comparison of the new Iwen, P.C., Rupp, M.E., Schreckenberger, P.C., Hinrichs, S.H., 1999. Evaluation of the
API Candida system to the ID 32C system for identification of clinically important revised MicroScan dried overnight gram-positive identification panel to identify
yeast species. J. Clin. Microbiol. 34, 1846–1848. Enterococcus species. J. Clin. Microbiol. 37, 3756–3758.
Fujii, I., Iwabuchi, Y., Teshima, T., Shiba, T., Kikuchi, M., 1993. X-Neu5Ac: a novel Jackson, C.R., Fedorka-Cray, P.J., Barrett, J.B., 2004. Use of a genus- and species-specific
substrate for chromogenic assay of neuraminidase activity in bacterial expression multiplex PCR for identification of enterococci. J. Clin. Microbiol. 42, 3558–3565.
systems. Bioorg. Med. Chem. 1, 147–149. Jacob, F., Monod, J., 1961. Genetic regulatory mechanisms in the synthesis of proteins.
Funke, G., Funke-Kissling, P., 2004. Evaluation of the new VITEK 2 Card for identification J. Mol. Biol. 3, 318–356.
of clinically relevant Gram-negative rods. J. Clin. Microbiol. 42, 4067–4071. James, A.L., Yeoman, P., 1988. Detection of specific bacterial enzymes by high contrast
Funke, G., Funke-Kissling, P., 2005. Performance of the new VITEK 2 GP card for metal chelate formation. Part II. Specific detection of Escherichia coli on multipoint-
identification of medically relevant Gram-positive cocci in a routine clinical inoculated plates using 8-hydroxyquinoline-beta-D-glucuronide. Zentralbl. Bakter-
laboratory. J. Clin. Microbiol. 43, 84–88. iol. Mikrobiol. Hyg. [A]. 267, 316–321.
Funke, G., Renaud, F.N., Freney, J., Riegel, P., 1997. Multicenter evaluation of the updated James, A.L., Yeoman, P., Rasburn, J.W., Ng, M., 1986. Sensitive reagents for detection of indole
and extended API (RAPID) Coryne database 2.0. J. Clin. Microbiol. 35, 3122–3126. production by bacteria. Zentralbl. Bakteriol. Mikrobiol. Hyg. [A]. 262, 195–202.
Funke, G., Peters, K., Aravena-Roman, M., 1998. Evaluation of the RapID CB Plus system James, A.L., Perry, J.D., Ford, M., Armstrong, L., Gould, F.K., 1996. Evaluation of cyclo-
for identification of coryneform bacteria and Listeria spp. J. Clin. Microbiol. 36, hexenoesculetin-beta-D-galactoside and 8-hydroxyquinoline-beta-D-galactoside as sub-
2439–2442. strates for the detection of beta-galactosidase. Appl. Environ. Microbiol. 62, 3868–3870.
Gaillot, O., Di Camillo, P., Berche, P., Courcol, R., Savage, C., 1999. Comparison of James, A.L., Perry, J.D., Ford, M., Armstrong, L., Gould, F.K., 1997. Note: cyclohex-
CHROMagar Salmonella medium and Hektoen enteric agar for isolation of Salmo- enoesculetin-beta-D-glucoside: a new substrate for the detection of bacterial beta-
nellae from stool samples. J. Clin. Microbiol. 37, 762–765. D-glucosidase. J. Appl. Microbiol. 82, 532–536.
Gaillot, O., Wetsch, M., Fortineau, N., Berche, P., 2000. Evaluation of CHROMagar S. James, A.L., Chilvers, K.F., Perry, J.D., Armstrong, L., Gould, F.K., 2000a. Evaluation of p-
aureus, a new chromogenic medium, for isolation and presumptive identification of naphtholbenzein-beta-D-galactoside as a substrate for bacterial beta-galactosidase.
Staphylococcus aureus from human clinical specimens. J. Clin. Microbiol. 38, Appl. Environ. Microbiol. 66, 5521–5523.
1587–1591. James, A.L., Perry, J.D., Chilvers, K., Robson, I.S., Armstrong, L., Orr, K.E., 2000b. Alizarin-
Gavin, S.E., Leonard, R.B., Briselden, A.M., Coyle, M.B., 1992. Evaluation of the rapid beta-D-galactoside: a new substrate for the detection of bacterial beta-galactosi-
CORYNE identification system for Corynebacterium species and other coryneforms. dase. Lett. Appl. Microbiol. 30, 336–340.
J. Clin. Microbiol. 30, 1692–1695. James, A.L., Perry, J.D., Jay, C., Monget, D., Rasburn, J.W., Gould, F.K., 2001. Fluorogenic
Geiger, R., Schneider, E., Wallenfels, K., Miska, W., 1992. A new ultrasensitive bio- substrates for the detection of microbial nitroreductases. Lett. Appl. Microbiol. 33,
luminogenic enzyme substrate for β-galactosidase. Biol. Chem. Hoppe-Seyler 373, 403–408.
1187–1191. James, A.L., Perry, J.D., Rigby, A., Stanforth, S.P., 2007. Synthesis and evaluation of novel
Giger, O., Charilaou, C.C., Cundy, K.R., 1984. Comparison of the API Staph-Ident and DMS chromogenic aminopeptidase substrates for microorganism detection and identi-
Staph-Trac systems with conventional methods used for the identification of fication. Bioorg. Med. Chem. Lett. 17, 1418–1421.
coagulase-negative staphylococci. J. Clin. Microbiol. 19, 68–72. Janda, W.M., Malloy, P.J., Schreckenberger, P.C., 1987. Clinical evaluation of the Vitek
Glupczynski, Y., Berhin, C., Bauraing, C., Bogaerts, P., 2007. Evaluation of a new selective Neisseria–Haemophilus Identification card. J. Clin. Microbiol. 25, 37–41.
chromogenic agar medium for detection of extended-spectrum beta-lactamase- Janda, W.M., Bradna, J.J., Ruther, P., 1989. Identification of Neisseria spp., Haemophilus
producing Enterobacteriaceae. J. Clin. Microbiol. 45, 501–505. spp., and other fastidious Gram-negative bacteria with the MicroScan Haemophilus–
Goodfellow, M., Thomas, E.G., James, A.L., 1987. Characterisation of rhodococci using Neisseria identification panel. J. Clin. Microbiol. 27, 869–873.
peptide hydrolase substrates based on 7-amino-4-methylcoumarin. FEMS Micro- Juergensmeyer, M.A., Gingras, B.A., Restaino, L., Frampton, E.W., 2006. A selective
biol. Lett. 43, 349–355. chromogenic agar that distinguishes Bacillus anthracis from Bacillus cereus and
Goodfellow, M., Thomas, E.G., Ward, A.C., James, A.L., 1990. Classification and identi- Bacillus thuringiensis. J. Food Prot. 69, 2002–2006.
fication of rhodococci. Zentralbl. Bakteriol. 274, 299–315. Kiernan, J.A., 2007. Indigogenic substrates for detection and localization of enzymes.
Gorm Jensen, T., Bossen Konradsen, H., Bruun, B., 1999. Evaluation of the Rapid ID 32 Biotech. Histochem. 82, 73–103.
Strep system. Clin. Microbiol. Infect. 5, 417–423. Kikuchi, K., Enari, T., Totsuka, K., Shimizu, K., 1995. Comparison of phenotypic charac-
Grant, C.E., Sewell, D.L., Pfaller, M., Bumgardner, R.V., Williams, J.A., 1994. Evaluation of teristics, DNA–DNA hybridization results, and results with a commercial rapid
two commercial systems for identification of coagulase-negative staphylococci to biochemical and enzymatic reaction system for identification of viridans group
species level. Diagn. Microbiol. Infect. Dis. 18, 1–5. streptococci. J. Clin. Microbiol. 33, 1215–1222.
Grollier, G., Burucoa, C., Bonnin, M., de Rautlin de La Roy, Y., 1992. Identification and Kilian, M., Bülow, P., 1979. Use of a β-glucuronidase detecting agar medium (PGUA
susceptibility testing for obligate anaerobic bacteria using a semi-automated API agar) for the identification of Escherichia coli in primary cultures of urine samples.
ATB plus system. Ann. Biol. Clin. (Paris) 50, 393–397. Acta Path. Microbiol. Scand. 8, 271–276.
Groom, S.C., Hazlett, M.J., Little, P.B., 1986. An evaluation of the API ZYM system as a Kim, M., Heo, S.R., Choi, S.H., Kwon, H., Park, J.S., Seoung, M.-W., Lee, D.-H., Park, K.U.,
means of identifying Haemophilus somnus and related taxa. Can. J. Vet. Res. 50, Song, J., Kim, E.-C., 2008. Comparison of MicroScan, VITEK 2 and Crystal GP with
238–244. 16S rRNA sequencing and MicroSeq 500 v2.0 analysis for coagulase-negative
Hara-Kudo, Y., Nishina, T., Nakagawa, H., Konuma, H., Hasegawa, J., Kumugai, S., 2001. staphylococci. BMC Microbiol. 8, 233–239.
Improved method for detection of Vibrio parahaemolyticus in seafood. Appl. Kitch, T.T., Appelbaum, P.C., 1989. Accuracy and reproducibility of the 4-hour ATB 32A
Environ. Microbiol. 67, 5819–5823. method for anaerobe identification. J. Clin. Microbiol. 27, 2509–2513.
Hata, D.J., Hall, L., Fothergill, A.W., Larone, D.H., Wengenack, N.L., 2007. Multicenter Kitch, T.T., Jacobs, M.R., Appelbaum, P.C., 1992. Evaluation of the 4-hour RapID NF Plus
evaluation of the new VITEK 2 advanced colorimetric yeast identification card. method for identification of 345 Gram-negative nonfermentative rods. J. Clin.
J. Clin. Microbiol. 45, 1087–1092. Microbiol. 30, 1267–1270.
Hayek, L.J., Willis, G.W., 1976. A comparison of two commerical methods for the Kitch, T.T., Jacobs, M.R., Appelbaum, P.C., 1994. Evaluation of RapID onE system for
identification of the Enterobacteriaceae–API 20E and the Enterotube—with identification of 379 strains in the family Enterobacteriaceae and oxidase-negative,
conventional methods. J. Clin. Pathol. 29, 158–161. gram-negative nonfermenters. J. Clin. Microbiol. 32, 931–934.
Heelan, J.S., Sotomayor, E., Coon, K., D'Arezzo, J.B., 1998. Comparison of the Rapid Yeast Kitch, T.T., Jacobs, M.R., McGinnis, M.R., Appelbaum, P.C., 1996. Ability of RapID Yeast
Plus panel with the API20C yeast system for identification of clinically significant Plus system to identify 304 clinically significant yeasts within 5 hours. J. Clin.
isolates of Candida species. J. Clin. Microbiol. 36, 1443–1445. Microbiol. 34, 1069–1071.
S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155 153

Laine, L., Perry, J.D., Lee, J., Oliver, M., James, A.L., De La Foata, C., Halimi, D., Orenga, S., O'Hara, C.M., 2006. Evaluation of the Phoenix 100 ID/AST system and NID panel for
Galloway, A., Gould, F.K., 2009. A novel chromogenic medium for isolation of Pseudo- identification of Enterobacteriaceae, Vibrionaceae, and commonly isolated nonen-
monas aeruginosa from the sputa of cystic fibrosis patients. J. Cyst. Fibros. 8, 143–149. teric Gram-negative bacilli. J. Clin. Microbiol. 44, 928–933.
Land, G., Stotler, R., Land, K., Staneck, J., 1984. Update and evaluation of the AutoMicrobic O'Hara, C.M., Miller, J.M., 1992. Evaluation of the autoSCAN-W/A system for rapid
yeast identification system. J. Clin. Microbiol. 20, 649–652. (2-hour) identification of members of the family Enterobacteriaceae. J. Clin. Microbiol.
Land, G.A., Salkin, I.F., el-Zaatari, M., McGinnis, M.R., Hashem, G., 1991. Evaluation of 30, 1541–1543.
the Baxter-MicroScan 4-hour enzyme-based yeast identification system. J. Clin. O'Hara, C.M., Miller, J.M., 1999. Evaluation of the ID 32E for the identification of Gram-
Microbiol. 29, 718–722. negative glucose-fermenting and glucose-non-fermenting bacilli. Clin. Microbiol.
Layer, F., Ghebremedhin, B., Moder, K.-A., Konig, W., Konig, B., 2006. Comparative study Infect. 5, 277–281.
using various methods for identification of Staphylococcus species in clinical O'Hara, C.M., Miller, J.M., 2000. Evaluation of the MicroScan rapid neg ID3 panel for
specimens. J. Clin. Microbiol. 44, 2824–2830. identification of Enterobacteriaceae and some common Gram-negative nonfermen-
Le Minor, L., Ben Hamida, F., 1962. Avantages de la recherche de la β-galactosidase sur celle ters. J. Clin. Microbiol. 38, 3577–3580.
de la fermentation du lactose en milieu complexe dans le diagnostic bacteriologique, O'Hara, C.M., Miller, J.M., 2002. Ability of the MicroScan rapid Gram-negative ID type 3
en particulier des Enterobacteriaceae. Ann. Inst. Pasteur. 102, 267–277. panel to identify nonenteric glucose-fermenting and nonfermenting Gram-
Ledeboer, N.A., Das, K., Eveland, M., Roger-Dalbert, C., Mailler, S., Chatellier, S., Dunne, negative bacilli. J. Clin. Microbiol. 40, 3750–3752.
W.M., 2007. Evaluation of a novel chromogenic agar medium for isolation and O'Hara, C.M., Miller, J.M., 2003. Evaluation of the Vitek 2 ID-GNB assay for identi-
differentiation of vancomycin-resistant Enterococcus faecium and Enterococcus fication of members of the family Enterobacteriaceae and other nonenteric Gram-
faecalis isolates. J. Clin. Microbiol. 45, 1556–1560. negative bacilli and comparison with the Vitek GNI+ Card. J. Clin. Microbiol. 41,
Lederberg, J., 1950. The beta-D-galactosidase of Escherichia coli, strain K-12. J. Bacteriol. 2096–2101.
60, 381–392. O'Hara, C.M., Tenover, F.C., Miller, J.M., 1993. Parallel comparison of accuracy of API
Lee, J.H., Huang, M.Z., Wu, J.L., Tsai, W.C., 1994. Assessment of a new four-hour 20E, Vitek GNI, MicroScan Walk/Away Rapid ID, and Becton Dickinson Cobas Micro
diagnostic kit -RapID onE system for the identification of enteric bacteria. Chin. J. ID-E/NF for identification of members of the family Enterobacteriaceae and common
Microbiol. Immunol. 27, 133–139. Gram-negative, non-glucose-fermenting bacilli. J. Clin. Microbiol. 31, 3165–3169.
Lehner, A., Nitzsche, S., Breeuwer, P., Diep, B., Thelen, K., Stephan, R., 2006. Comparison O'Hara, C.M., Westbrook, G.L., Miller, J.M., 1997. Evaluation of Vitek GNI+ and Becton
of two chromogenic media and evaluation of two molecular based identification Dickinson Microbiology Systems Crystal E/NF identification systems for identification
systems for Enterobacter sakazakii detection. BMC Microbiol. 6, 15–22. of members of the family Enterobacteriaceae and other Gram-negative, glucose-
Manafi, M., 1996. Fluorogenic and chromogenic enzyme substrates in culture media fermenting and non-glucose-fermenting bacilli. J. Clin. Microbiol. 35, 3269–3273.
and identification tests. Int. J. Food Microbiol. 31, 45–58. Olsen, M.J., Stephens, D., Griffiths, D., Daugherty, P., Georgiou, G., Iverson, B.L., 2000.
Manafi, M., 2000. New developments in chromogenic and fluorogenic culture media. Function-based isolation of novel enzymes from a large library. Nat. Biotechnol. 18,
Int. J. Food Microbiol. 60, 205–218. 1071–1074.
Manafi, M., Kneifel, W., 1990. Rapid methods for differentiating Gram-positive from Gram- Palmieri, M.J., Carito, S.L., Meyer, R.F., 1988. Comparison of rapid NFT and API 20E with
negative aerobic and facultative anaerobic bacteria. J. Appl. Bacteriol. 69, 822–827. conventional methods for identification of Gram-negative nonfermentative bacilli
Manafi, M., Kremsmaier, B., 2001. Comparative evaluation of different chromogenic/ from pharmaceuticals and cosmetics. Appl. Environ. Microbiol. 54, 2838–2841.
fluorogenic media for detecting Escherichia coli O157:H7 in food. Int. J. Food Park, C.E., Rayman, M.K., Szabo, R., Stankiewicz, Z.K., 1976. Selective enrichment of
Microbiol. 71, 257–262. Shigella in the presence of Escherichia coli by use of 4-chloro-2-cyclopentylphe-
Manafi, M., Kneifel, W., Bascomb, S., 1991. Fluorogenic and chromogenic substrates nyl-beta-D-galactopyranoside. Can. J. Microbiol. 22, 654–657.
used in bacterial diagnostics. Microbiol. Rev. 55, 335–348. Pattyn, S.R., Ieven, M., Buffet, L., 1993. Comparative evaluation of the Rapid ID 32A kit
Markaryan, A.N., Voznyi, Y.V., 1992. 3-Cyano-4-trifluoromethylumbelliferyl-β-D-galac- system, miniaturized standard procedure and a rapid fermentation procedure for
topyranoside: synthesis, properties and application for β-galactosidase assay. Anal. the identification of anaerobic bacteria. Acta Clin. Belg. 48, 81–85.
Lett. 25, 681–694. Paugam, A., Benchetrit, M., Fiacre, A., Tourte-Schaefer, C., Dupouy-Camet, J., 1999.
Marler, L.M., Siders, J.A., Wolters, L.C., Pettigrew, Y., Skitt, B.L., Allen, S.D., 1991. Comparison of four commercialized biochemical systems for clinical yeast
Evaluation of the new RapID-ANA II system for the identification of clinical identification by colour-producing reactions. Med. Mycol. 37, 11–17.
anaerobic isolates. J. Clin. Microbiol. 29, 874–878. Pearson, B., Wolf, P., Andrews, M., 1963. The histochemical demonstration of leucine
Marston, C.K., Beesley, C., Helsel, L., Hoffmaster, A.R., 2008. Evaluation of two selective aminopeptidase by means of a new indolyl compound. Lab Invest. 12, 712–720.
media for the isolation of Bacillus anthracis. Lett. Appl. Microbiol. 47, 25–30. Perry, J.D., Freydière, A.M., 2007. The application of chromogenic media in clinical
Martin, R., Siavoshi, F., McDougal, D.L., 1986. Comparison of Rapid NFT system and microbiology. J. Appl. Microbiol. 103, 2046–2055.
conventional methods for identification of nonsaccharolytic Gram-negative bacteria. Perry, J.D., Archer, L., Jones, A.L., James, A.L., Ford, M., Gould, F.K., 1998. Detection of
J. Clin. Microbiol. 24, 1089–1092. carboxypeptidases as taxonomic markers for Gram-negative bacteria. Lett. Appl.
Mazoyer, M.A., Orenga, S., Doléans, F., Freney, J., 1995. Evaluation of CPS ID2 medium for Microbiol. 26, 359–362.
detection of urinary tract bacterial isolates in specimens from a rehabilitation Perry, J.D., Ford, M., Taylor, J., Jones, A.L., Freeman, R., Gould, F.K., 1999. ABC medium,
center. J. Clin. Microbiol. 33, 1025–1027. a new chromogenic agar for the selective isolation of Salmonella spp. J. Clin.
Miles, R.J., Siu, E.L., Carrington, C., Richardson, A.C., Smith, B.V., Price, R.G., 1992. The Microbiol. 37, 766–768.
detection of lipase activity in bacteria using novel chromogenic substrates. FEMS Perry, J.D., Riley, G., Gould, F.K., Perez, J.M., Boissier, E., Ouedraogo, R.T., Freydière, A.M.,
Microbiol. Lett. 69, 283–287. 2002. Alafosfalin as a selective agent for isolation of Salmonella from clinical
Miranda, J.M., Franco, C.M., Vázquez, B.I., Fente, C.A., Barros-Velázquez, J., Cepeda, A., samples. J. Clin. Microbiol. 40, 3913–3916.
2005. Evaluation of Chromocult enterococci agar for the isolation and selec- Perry, J.D., Rennison, C., Butterworth, L.A., Hopley, A.L.J., Gould, F.K., 2003. Evaluation of
tive enumeration of Enterococcus spp. in broilers. Lett. Appl. Microbiol. 41, 153–156. S. aureus ID, a new chromogenic agar medium for detection of Staphylococcus
Monget, D., 1975. Comparison of enzyme activity in two insect cell lines: Anthera aureus. J. Clin. Microbiol. 41, 5695–5698.
eucalypti and Malacosoma disstria (Lepidoptera). C. R. Acad. Sci. Hebd. Seances Acad. Perry, J.D., Davies, A., Butterworth, L.A., Hopley, A.L.J., Nicholson, A., Gould, F.K., 2004.
Sci. D. 281, 651–654. Development and evaluation of a chromogenic agar medium for methicillin-
Monnet, D., Lafay, D., Desmonceaux, M., Boeufgras, J.M., Allard, F., Freney, J., 1994. resistant Staphylococcus aureus. J. Clin. Microbiol. 42, 4519–4523.
Evaluation of a semi-automated 24-hour commercial system for identification of Perry, J.D., James, A.L., Morris, K.A., Oliver, M., Chilvers, K.F., Reed, R.H., Gould, F.K.,
Enterobacteriaceae and other Gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. 2006a. Evaluation of novel fluorogenic substrates for the detection of glycosidases
Dis. 13, 424–430. in Escherichia coli and enterococci. J. Appl. Microbiol. 101, 977–985.
Mory, F., Alauzet, C., Matuszewski, C., Riegel, P., Lozniewski, A., 2009. Evaluation of the Perry, J.D., Oliver, M., Nicholson, A., Wright, J., Gould, F.K., 2006b. Evaluation of a new
new Vitek 2 ANC card for identification of medically relevant anaerobic bacteria. chromogenic agar medium for isolation and identification of group B streptococci.
J. Clin. Microbiol. 47, 1923–1926. Lett. Appl. Microbiol. 43, 615–618.
Munson, E.L., Doern, G.V., 2007. Comparison of three commercial test systems for Perry, J.D., Morris, K.A., James, A.L., Oliver, M., Gould, F.K., 2007. Evaluation of novel
biotyping Haemophilus influenzae and Haemophilus parainfluenzae. J. Clin. Micro- chromogenic substrates for the detection of bacterial β-glucosidase. J. Appl.
biol. 45, 4051–4053. Microbiol. 102, 410–415.
Muytjens, H.L., van der Ros-van de Repe, J., van Druten, H.A., 1984. Enzymatic profiles of Pfaller, M.A., Preston, T., Bale, M., Koontz, F.P., Body, B.A., 1988. Comparison of the
Enterobacter sakazakii and related species with special reference to the alpha- Quantum II, API Yeast Ident, and AutoMicrobic systems for identification of clinical
glucosidase reaction and reproducibility of the test system. J. Clin. Microbiol. 20, yeast isolates. J. Clin. Microbiol. 26, 2054–2058.
684–686. Pfaller, M.A., Sahm, D., O'Hara, C., Ciaglia, C., Yu, M., Yamane, N., Scharnweber, G.,
Nakashima, Y., Oho, M., Kusaba, K., Nagasawa, Z., Komatsu, O., Manome, I., Araki, K., Rhoden, D., 1991. Comparison of the autoSCAN-W/A rapid bacterial identification
Oishi, H., Nakashima, M., 2007. A chromogenic substrate culture plate for early system and the Vitek AutoMicrobic system for identification of Gram-negative
identification of Vibrio vulnificus and isolation of other marine Vibrios. Ann. Clin. bacilli. J. Clin. Microbiol. 29, 1422–1428.
Lab. Sci. 37, 330–334. Philip, A., Garton, G.C., 1985. Comparative evaluation of five commercial systems for the
Nakazono, M., Nohta, H., Sasamoto, K., Ohkura, Y., 1992. Chemiluminescent assays for rapid identification of pathogenic Neisseria species. J. Clin. Microbiol. 22, 101–104.
β-D-galactosidase and alkaline phosphatase using novel luminol derivatives as Pócsi, I., Taylor, S.A., Richardson, A.C., Asmild, K.H., Smith, B.V., Price, R.G., 1990. “VRA-
substrates. Anal. Sci. 8, 779–783. GlcNAc”: novel substrate for N-acetyl-β-D-glucosaminidase applied to assay of this
Nelis, H., Van Poucke, S., 2000. Enzymatic detection of coliforms and Escherichia coli enzyme in urine. Clin. Chem. 36, 1884–1888.
within 4 hours. Water, Air, Soil Poll. 123, 43–52. Poulsen, L.K., Dalton, H.M., Angles, M.L., Marshall, K.C., Molin, S., Goodman, A.E., 1997.
Odds, F.C., Bernaerts, R., 1994. CHROMagar Candida, a new differential isolation Simultaneous determination of gene expression and bacterial identity in
medium for presumptive identification of clinically important Candida species. single cells in defined mixtures of pure cultures. Appl. Environ. Microbiol. 63,
J. Clin. Microbiol. 32, 1923–1929. 3698–3702.
154 S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155

Randall, L.P., Kirchner, M., Teale, C.J., Coldham, N.G., Liebana, E., Clifton-Hadley, F., 2009. Stoakes, L., Schieven, B.C., Ofori, E., Ewan, P., Lannigan, R., Hussain, Z., 1992. Evaluation
Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive of MicroScan Rapid Pos Combo panels for identification of staphylococci. J. Clin.
Enterobacteriaceae while inhibiting AmpC-producing strains. J. Antimicrob. Che- Microbiol. 30, 93–95.
mother. 63, 302–308. Su, Y.C., Duan, J., Wu, W.H., 2005. Selectivity and specificity of a chromogenic medium
Reina, J., Ros, M.J., Serra, A., 1995. Evaluation of the API-Campy System in the bio- for detecting Vibrio parahaemolyticus. J. Food Prot. 68, 1454–1456.
chemical identification of hippurate negative Campylobacter strains isolated from Sung, L.L., Yang, D.I., Hung, C.C., Ho, H.T., 2000. Evaluation of autoSCAN-W/A and the
faeces. J. Clin. Pathol. 48, 683–685. Vitek GNI+ AutoMicrobic system for identification of non-glucose-fermenting
Reissbrodt, R., 2004. New chromogenic plating media for detection and enumeration of Gram-negative bacilli. J. Clin. Microbiol. 38, 1127–1130.
pathogenic Listeria spp.—an overview. Int. J. Food Microbiol. 95, 1–9. Sutton, L.D., Biedenbach, D.J., Yen, A., Jones, R.N., 1995. Development, characterization,
Renaud, F.N.R., Bergeron, E., Tigaud, S., Fuhrmann, C., Gravagna, B., Freney, J., 2005. Evaluation and initial evaluations of S1. A new chromogenic cephalosporin for beta-lactamase
of the new Vitek 2 GN card for the identification of Gram-negative bacilli frequently detection. Diagn. Microbiol. Infect. Dis. 21, 1–8.
encountered in clinical laboratories. Eur. J. Clin. Microbiol. Infect. Dis. 24, 671–676. Tazi, A., Doloy, A., Réglier-Poupet, H., Hemet, M.E., Raymond, J., Poyart, C., 2009.
Renneberg, J., Rieneck, K., Gutschik, E., 1995. Evaluation of Staph ID 32 system and Evaluation of the new chromogenic medium StrepB Select for screening of group B
Staph-Zym system for identification of coagulase-negative staphylococci. J. Clin. Streptococcus in pregnant women. Pathol. Biol. (Paris). 57, 225–228.
Microbiol. 33, 1150–1153. Tharagonnet, D., Sisson, P.R., Roxby, C.M., Ingham, H.R., Selkon, J.B., 1977. The API ZYM
Rennie, R.P., Brosnikoff, C., Shokoples, S., Reller, L.B., Mirrett, S., Janda, W., Ristow, K., system in the identification of Gram-negative anaerobes. J. Clin. Pathol. 30,
Krilcich, A., 2008a. Multicenter evaluation of the Vitek 2 Anaerobe and Coryne- 505–509.
bacterium identification card. J. Clin. Microbiol. 46, 2646–2651. Torlak, E., Akan, I.M., Gökmen, M., 2008. Comparison of TEMPO EC and TBX medium for
Rennie, R.P., Brosnikoff, C., Shokoples, S., Reller, L.B., Mirrett, S., Janda, W., Ristow, K., the enumeration of Escherichia coli in cheese. Lett. Appl. Microbiol. 47, 566–570.
Krilcich, A., 2008b. Multicenter evaluation of the new Vitek 2 Neisseria–Haemophilus Valenza, G., Ruoff, C., Vogel, U., Frosch, M., Abele-Horn, M., 2007. Microbiological
identification card. J. Clin. Microbiol. 46, 2681–2685. evaluation of the new VITEK 2 Neisseria–Haemophilus identification card. J. Clin.
Restaino, L., Frampton, E.W., Lionberg, W.C., Becker, R.J., 2006. A chromogenic plating Microbiol. 45, 3493–3497.
medium for the isolation and identification of Enterobacter sakazakii from foods, Valenza, G., Strasen, J., Schafer, F., Frosch, M., Kurzai, O., Abele-Horn, M., 2008. Evalua-
food ingredients, and environmental sources. J. Food Prot. 69, 315–322. tion of new colorimetric Vitek 2 yeast identification card by use of different source
Reymond, J.L., Fluxà, V.S., Maillard, N., 2009. Enzyme assays. Chem. Commun. (Camb). 7, media. J. Clin. Microbiol. 46, 3784–3787.
34–46. Vail, J.H., Morgan, R., Merino, C.R., Gonzales, F., Miller, R., Ram, J.L., 2003. Eumeration of
Riddle, D.L., Giger, O., Miller, L., Hall, G.S., Woods, G.L., 1994. Clinical comparison of the waterborne Escherichia coli with petrifilm plates: comparison to standard methods.
Baxter MicroScan Yeast Identification Panel and the Vitek Yeast Biochemical Card. J. Environ. Qual. 32, 368–373.
Am. J. Clin. Pathol. 101, 438–442. Van Ommen Kloeke, F., Baty 3rd, A.M., Eastburn, C.C., Diwu, Z., Geesey, G.G., 1999. Novel
Robinson, M.J., Oberhofer, T.R., 1983. Identification of pathogenic Neisseria species with method for screening bacterial colonies for phosphatase activity. J. Microbiol.
the RapID NH system. J. Clin. Microbiol. 17, 400–404. Methods. 38, 25–31.
Robinson, A., McCarter, Y.S., Tetreault, J., 1995. Comparison of Crystal Enteric/ Van Poucke, S.O., Nelis, H.J., 1995. Development of a sensitive chemiluminometric assay for
Nonfermenter system, API 20E system, and Vitek AutoMicrobic system for the detection of β-galactosidase in permeabilized coliform bacteria and comparison
identification of Gram-negative bacilli. J. Clin. Microbiol. 33, 364–370. with fluorometry and colorimetry. Appl. Environ. Microbiol. 61, 4505–4509.
Rothe, G., Klingel, S., Assfalg-Machleidt, I., Machleidt, W., Zirkelbach, C., Banati, R.B., Van Poucke, S.O., Nelis, H.J., 2000a. A 210-min solid phase cytometry test for the
Mangel, W.F., Valet, G., 1992. Flow cytometric analysis of protease activities in vital enumeration of Escherichia coli in drinking water. J. Appl. Microbiol. 89, 390–396.
cells. Biol. Chem. Hoppe Seyler. 373, 547–554. Van Poucke, S.O., Nelis, H.J., 2000b. Rapid detection of fluorescent and chemilumines-
Ruoff, K.L., Kunz, L.J., 1983. Use of the Rapid STREP system for identification of viridans cent total coliforms and Escherichia coli on membrane filters. J. Microbiol. Meth. 42,
streptococcal species. J. Clin. Microbiol. 18, 1138–1140. 233–244.
Ryan, M., Huang, J.C., Griffith, O.H., Keana, J.F., Volwerk, J.J., 1993. A chemiluminescent Vandamme, P., Pot, B., Gillis, M., De Vos, P., Kersters, K., Swings, J., 1996. Polyphasic
substrate for the detection of phosphatidylinositol-specific phospholipase C. Anal. taxonomy, a consensus approach to bacterial systematics. Microbiol. Rev. 60, 407–438.
Biochem. 214, 548–556. Vencill, C.F., Rasnick, D., Crumley, K.V., Nishino, N., Powers, J.C., 1985. Clostridium
Sáa, A.I., Vivas, J., Tinajas, A., Barbeyto, L., Rodriguez, L.A., 1999. Evaluation of the histolyticum collagenase: development of new thio ester, fluorogenic, and
MicroScan system for identification of staphylococci. J. Basic Microbiol. 39, 373–376. depsipeptide substrates and new inhibitors. Biochemistry 24, 3149–3157.
Sadler, P.W., Warren, R.L., 1956. Synthesis and absorption spectra of the symmetrical Vernozy-Rozand, C., Mazuy-Cruchaudet, C., Bavai, C., Montet, M.P., Bonin, V.,
chloroindigos. J. Am. Chem. Soc. 78, 1251–1255. Dernburg, A., Richard, Y., 2005. Growth and survival of Escherichia coli O157:H7
Sanguinetti, M., Porta, R., Sali, M., La Sorda, M., Pecorini, G., Fadda, G., Posteraro, B., 2007. during the manufacture and ripening of raw goat milk lactic cheeses. Int. J. Food
Evaluation of VITEK 2 and RapID Yeast Plus systems for yeast species identification: Microbiol. 105, 83–88.
experience at a large clinical microbiology laboratory. J. Clin. Microbiol. 45, 1343–1346. von Baum, H., Klemme, F.R., Geiss, H.K., Sonntag, H.G., 1998. Comparative evaluation
Schönenbrücher, V., Mallinson, E.T., Bülte, M., 2008. A comparison of standard cultural of a commercial system for identification of Gram-positive cocci. Eur. J. Clin.
methods for the detection of foodborne Salmonella species including three new Microbiol. Infect. Dis. 17, 849–852.
chromogenic plating media. Int. J. Food Microbiol. 123, 61–66. von Graevenitz, A., Zollinger-Iten, J., 1985. Evaluation of pertinent parameters of a new
Schreckenberger, P.C., Celig, D.M., Janda, W.M., 1988. Clinical evaluation of the identification system for non-enteric Gram-negative rods. Eur. J. Clin. Microbiol. 4,
Vitek ANI card for identification of anaerobic bacteria. J. Clin. Microbiol. 26, 108–112.
225–230. Wadlin, J.K., Hanko, G., Stewart, R., Pape, J., Nachamkin, I., 1999. Comparison of three
Schreckenberger, P.C., Ristow, K.L., Krilcich, A.M., 2005. Comparison of the Vitek commercial systems for identification of yeasts commonly isolated in the clinical
Legacy, Vitek 2 colorimetric and Phoenix systems for identification of fermenting microbiology laboratory. J. Clin. Microbiol. 37, 1967–1970.
and non-fermenting bacteria of clinical origin. Poster C-193. 105th General Waitkins, S.A., Ball, L.C., Fraser, C.A., 1980. Use of the API-ZYM system in rapid
Meeting of the American Society for Microbiology, Atlanta, GA. identification of alpha and non-haemolytic streptococci. J. Clin. Pathol. 33,
Seidman, M., Link, K.P., 1950. O-nitrophenyl-β-D-galactopyranoside and its tetraace- 53–57.
tate. J. Am. Chem. Soc. 72, 4324. Wallet, F., Loiez, C., Renaux, E., Lemaitre, N., Courcol, R.J., 2005. Performances of VITEK 2
Shih, D.Y., 2000. Isolation and identification of enteropathogenic Campylobacter spp. colorimetric cards for identification of Gram-positive and Gram-negative bacteria.
from chicken samples in Taipei. J. Food Prot. 63, 304–308. J. Clin. Microbiol. 43, 4402–4406.
Smith, M.B., Dunklee, D., Vu, H., Woods, G.L., 1999. Comparative performance of the Warren, B.R., Parish, M.E., Schneider, K.R., 2005. Comparison of chromogenic Shigella
RapID Yeast Plus system and the API 20C AUX clinical yeast system. J. Clin. spp. plating medium with standard media for the recovery of Shigella boydii and
Microbiol. 37, 2697–2698. Shigella sonnei from tomato surfaces. J. Food Prot. 68, 621–624.
Song, K.Y., Hyeon, J.Y., Shin, H.C., Park, C.K., Choi, I.S., Seo, K.H., 2008. Evaluation of a Watts, J.L., 1989. Evaluation of the Rapid Strep system for identification of gram-
chromogenic medium supplemented with glucose for detecting Enterobacter positive, catalase-negative cocci isolated from bovine intramammary infections.
sakazakii. J. Microbiol. Biotechnol. 18, 579–584. J. Dairy Sci. 72, 2728–2732.
Soto, A., Zapardiel, J., Soriano, F., 1994. Evaluation of API Coryne system for identifying Wauters, G., Boel, A., Voorn, G.P., Verhaegen, J., Meunier, F., Janssens, M., Verbist, L.,
coryneform bacteria. J. Clin. Pathol. 47, 756–759. 1995. Evaluation of a new identification system, Crystal Enteric/Non-Fermenter, for
Sperner, B., Eisgruber, H., Stolle, A., 1999. Use of the RAPID ID 32 A system for rapid Gram-negative bacilli. J. Clin. Microbiol. 33, 845–849.
identification of Clostridium species important in food hygiene. Int. J. Food Weagant, S.D., 2008. A new chromogenic agar medium for detection of potentially
Microbiol. 52, 169–180. virulent Yersinia enterocolitica. J. Microbiol. Meth. 72, 185–190.
St.-Germain, G., Beauchesne, D., 1991. Evaluation of the MicroScan Rapid Yeast Weinstein, M.P., Mirrett, S., Van Pelt, L., McKinnon, M., Zimmer, B.L., Kloos, W.,
Identification panel. J. Clin. Microbiol. 29, 2296–2299. Reller, L.B., 1998. Clinical importance of identifying coagulase-negative staphy-
Stefaniuk, E., Baraniak, A., Gniadkowski, M., Hryniewicz, W., 2003. Evaluation of lococci isolated from blood cultures: evaluation of MicroScan Rapid and dried
the BD Phoenix automated identification and susceptibility testing system in overnight Gram-Positive panels versus a conventional reference method. J. Clin.
clinical microbiology laboratory practice. Eur. J. Clin. Microbiol. Infect. Dis. 22, Microbiol. 36, 2089–2092.
479–485. Willey, B.M., Kreiswirth, B.N., Simor, A.E., Faur, Y., Patel, M., Williams, G., Low, D.E.,
Stessl, B., Luf, W., Wagner, M., Schoder, D., 2009. Performance testing of six chro- 1993. Identification and characterization of multiple species of vancomycin-
mogenic ALOA-type media for the detection of Listeria monocytogenes. J. Appl. resistant enterococci, including an evaluation of Vitek software version 7.1. J. Clin.
Microbiol. 106, 651–659. Microbiol. 31, 2777–2779.
Stoakes, L., Kelly, T., Manarin, K., Schieven, B., Lannigan, R., Groves, D., Hussain, Z., 1990. Wolf, P.L., Horwitz, J., Mandeville, R., Vazquez, J., Von der Muehll, E., 1969. A new and
Accuracy and reproducibility of the MicroScan rapid anaerobe identification system unique method for detecting bacterial deoxyribonuclease in the clinical laboratory.
with an automated reader. J. Clin. Microbiol. 28, 1135–1138. Tech. Bull. Regist. Med. Technol. 39, 83–86.
S. Orenga et al. / Journal of Microbiological Methods 79 (2009) 139–155 155

You, M.S., Facklam, R.R., 1986. New test system for identification of Aerococcus, Enter- Zhang, Y.Z., Naleway, J.J., Larison, K.D., Huang, Z.J., Haugland, R.P., 1991. Detecting lacZ
ococcus, and Streptococcus species. J. Clin. Microbiol. 24, 607–611. gene expression in living cells with new lipophilic, fluorogenic beta-galactosidase
Zaytsev, A.V., Anderson, R.J., Bedernjak, A., Groundwater, P.W., Huang, Y., Perry, J.D., substrates. FASEB J. 5, 3108–3113.
Orenga, S., Roger-Dalbert, C., James, A.L., 2008. Synthesis and testing of chro- Zhong, W., Murphy, D.J., Georgopapadakou, N.H., 1999. Inhibition of yeast inositol
mogenic phenoxazinone substrates for beta-alanyl aminopeptidase. Org. Biomol. phosphorylceramide synthase by aureobasidin A measured by a fluorometric assay.
Chem. 6, 682–692. FEBS Lett. Dec. 17, 241–244.

Das könnte Ihnen auch gefallen